Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 41
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Continuous flexibility analysis of SARS-CoV-2 spike prefusion structures

  • Melero, Roberto
  • Sorzano, Carlos Óscar S.
  • Foster, Brent
  • Vilas, José Luis
  • Martínez, Marta
  • Marabini, Roberto
  • Ramírez-Aportela, Erney
  • Sánchez-García, Rubén
  • Herreros, David
  • Caño, Laura del
  • Losana, Patricia
  • Fonseca-Reyna, Yunior C.
  • Conesa Mingo, Pablo
  • Wrapp, Daniel
  • Chacón, Pablo
  • McLellan, Jason S.
  • Tagare, Hemant D.
  • Carazo, José M.
Using a new consensus-based image-processing approach together with principal component analysis, the flexibility and conformational dynamics of the SARS-CoV-2 spike in the prefusion state have been analysed. These studies revealed concerted motions involving the receptor-binding domain (RBD), N-terminal domain, and subdomains 1 and 2 around the previously characterized 1-RBD-up state, which have been modeled as elastic deformations. It is shown that in this data set there are not well defined, stable spike conformations, but virtually a continuum of states. An ensemble map was obtained with minimum bias, from which the extremes of the change along the direction of maximal variance were modeled by flexible fitting. The results provide a warning of the potential image-processing classification instability of these complicated data sets, which has a direct impact on the interpretability of the results., The authors would like to acknowledge financial support from CSIC (PIE/COVID-19 No. 202020E079), the Comunidad de Madrid through grant CAM (S2017/BMD-3817), the Spanish Ministry of Science and Innovation through projects SEV 2017-0712, FPU-2015/264 and PID2019-104757RB-I00/AEI/FEDER, the Instituto de Salud Carlos III [PT17/0009/0010 (ISCIII-SGEFI/ERDF)], and the European Union and Horizon 2020 through grants INSTRUCT–ULTRA (INFRADEV-03-2016-2017, Proposal 731005), EOSC Life (INFRAEOSC-04-2018, Proposal 824087), HighResCells (ERC-2018-SyG, Proposal 810057), IMpaCT (WIDESPREAD-03-2018, Proposal 857203), CORBEL (INFRADEV-1-2014-1, Proposal 654248) and EOSC–Synergy (EINFRA-EOSC-5, Proposal 857647). HDT and BF were supported by NIH grant GM125769 and JSM was supported by NIH grant R01-AI127521., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

The turning point and end of an expanding epidemic cannot be precisely forecast

  • Castro, Mario
  • Ares, Saúl
  • Cuesta, José A.
  • Manrubia Cuevas, Susanna
Epidemic spread is characterized by exponentially growing dynamics, which are intrinsically unpredictable. The time at which the growth in the number of infected individuals halts and starts decreasing cannot be calculated with certainty before the turning point is actually attained; neither can the end of the epidemic after the turning point. A susceptible–infected–removed (SIR) model with confinement (SCIR) illustrates how lockdown measures inhibit infection spread only above a threshold that we calculate. The existence of that threshold has major effects in predictability: A Bayesian fit to the COVID-19 pandemic in Spain shows that a slowdown in the number of newly infected individuals during the expansion phase allows one to infer neither the precise position of the maximum nor whether the measures taken will bring the propagation to the inhibition regime. There is a short horizon for reliable prediction, followed by a dispersion of the possible trajectories that grows extremely fast. The impossibility to predict in the midterm is not due to wrong or incomplete data, since it persists in error-free, synthetically produced datasets and does not necessarily improve by using larger datasets. Our study warns against precise forecasts of the evolution of epidemics based on mean-field, effective, or phenomenological models and supports that only probabilities of different outcomes can be confidently given., This research has been funded by the Spanish Ministerio de Ciencia, Innovación y Universidades (MICINN)-Fondo Europeo de Desarrollo Regional funds of the European Union support, under Projects FIS2016-78883-C2-2-P and PID2019-106339GB-I00 (to M.C.), PGC2018-098186-B-I00 (to J.A.C.), FIS2017-89773-P (to S.M.), FIS2016-78313-P (to S.A.), and PID2019-109320GB-100/AEI/10.13039/501100011033 (to S.A.). The Spanish MICINN has also funded the “Severo Ochoa” Centers of Excellence (to Centro Nacional de Biotecnología [CNB]) SEV 2017-0712 and Special Grant Proyecto Intramural Especial 2020-20E079 (to CNB, S.M. and S.A.) entitled “Development of protection strategies against SARS-CoV-2.”, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

The chaperonin CCT controls T cell receptor–driven 3D configuration of centrioles

  • Martín-Cófreces, Noa Beatriz
  • Chichón, Francisco Javier
  • Calvo, E.
  • Torralba, D.
  • Bustos-Moran, E.
  • Dosil, S. G.
  • Rojas-Gómez, Amelia
  • Bonzón-Kulichenko, Elena
  • Lopez, J. A.
  • Otón, Joaquín
  • Sorrentino, A.
  • Zabala, Juan Carlos
  • Vernos, I.
  • Vázquez, J.
  • Valpuesta, José M.
  • Sánchez-Madrid, Francisco
© 2020 The Authors., T lymphocyte activation requires the formation of immune synapses (IS) with antigen-presenting cells. The dynamics of membrane receptors, signaling scaffolds, microfilaments, and microtubules at the IS determine the potency of T cell activation and subsequent immune response. Here, we show that the cytosolic chaperonin CCT (chaperonin-containing TCP1) controls the changes in reciprocal orientation of the centrioles and polarization of the tubulin dynamics induced by T cell receptor in T lymphocytes forming an IS. CCT also controls the mitochondrial ultrastructure and the metabolic status of T cells, regulating the de novo synthesis of tubulin as well as posttranslational modifications (poly-glutamylation, acetylation, Δ1 and Δ2) of αβ-tubulin heterodimers, fine-tuning tubulin dynamics. These changes ultimately determine the function and organization of the centrioles, as shown by three-dimensional reconstruction of resting and stimulated primary T cells using cryo-soft x-ray tomography. Through this mechanism, CCT governs T cell activation and polarity., Cryo-SXT work was supported by ALBA Synchrotron standard proposals 2015021148 and 2016021638 to F.J.C., N.B.M.-C., and J.M.V. This study was supported by grants SAF2017-82886-R (to F.S.-M.), PID2019-105872GB I00/AEI/10.13039/501100011033 (AEI/FEDER, UE), BFU2016-75984 (to J.M.V.), and BIO2015-67580-P and PGC2018-097019-B-I00 (to J.V.) from the Spanish Ministry of Economy and Competitiveness (MINECO), grants INFLAMUNE-S2017/BMD-23671 (to F.S.-M.) and P2018/NMT-4389 (to J.M.V.) from the Comunidad de Madrid, ERC-2011-AdG 294340-GENTRIS (to F.S.-M.), a 2019 grant from the Ramón Areces Foundation “Ciencias de la Vida y la Salud” and a 2018 grant from Ayudas Fundación BBVA a Equipos de Investigación Científica (to F.S.-M.), and grants PRB3 (IPT17/0019-ISCIII-SGEFI/ERDF), the Fundació Marató TV3 (grant 122/C/2015), and “La Caixa” Banking Foundation (HR17-00016 to FSM and HR17-00247 to J.V.). D.T. is supported by a PhD fellowship from La Caixa Foundation. Work in the Vernos lab was supported by the grant CSD2006-00023 from the Spanish Ministry of Science and Innovation and grants BFU2012-37163 and BFU2015-68726-P from the Spanish Ministry of Economy and Competitiveness. The CRG acknowledges support of the Spanish Ministry of Science and Innovation to the EMBL partnership, the Centro de Excelencia Severo Ochoa, and the CERCA Programme/Generalitat de Catalunya. CIBER Cardiovascular (Fondo de Investigación Sanitaria del Instituto de Salud Carlos III and co-funding by Fondo Europeo de Desarrollo Regional FEDER). The Centro Nacional de Investigaciones Cardiovasculares (CNIC) is supported by the Spanish Ministry of Economy and Competitiveness (MINECO) and the Pro-CNIC Foundation and is a Severo Ochoa Center of Excellence (MINECO award SEV-2015-0505). The Centro Nacional de Biotecnología (CNB) is a Severo Ochoa Center of Excellence (MINECO award SEV 2017-0712).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Virucidal Action Mechanism of Alcohol and Divalent Cations Against Human Adenovirus

  • Martín-González, Natalia
  • Vieira Gonçalves, Leonam
  • Condezo, Gabriela N.
  • San Martín, Carmen
  • Rubiano, María
  • Fallis, Ian
  • Rubino, Joseph R.
  • Ijaz, M. Khalid
  • Maillard, Jean-Yves
  • Pablo, Pedro J. de
© 2020 Martín-González, Vieira Gonçalves, Condezo, San Martín, Rubiano, Fallis, Rubino, Ijaz, Maillard and De Pablo., Hygiene and disinfection practices play an important role at preventing spread of viral infections in household, industrial and clinical settings. Although formulations based on >70% ethanol are virucidal, there is a currently a need to reformulate products with much lower alcohol concentrations. It has been reported that zinc can increase the virucidal activity of alcohols, although the reasons for such potentiation is unclear. One approach in developing virucidal formulations is to understand the mechanisms of action of active ingredients and formulation excipients. Here, we investigated the virucidal activity of alcohol (40% w/v) and zinc sulfate (0.1% w/v) combinations and their impact on a human adenovirus (HAdV) using, nucleic acid integrity assays, atomic force microscopy (AFM) and transmission electron microscopy (TEM). We observed no difference in virucidal activity (5 log10 reduction in 60 min) against between an ethanol only based formulation and a formulation combining ethanol and zinc salt. Furthermore, TEM imaging showed that the ethanol only formulation produced gross capsid damage, whilst zinc-based formulation or formulation combining both ethanol and zinc did not affect HAdV DNA. Unexpectedly, the addition of nickel salt (5 mM NiCl2) to the ethanol-zinc formulation contributed to a weakening of the capsid and alteration of the capsid mechanics exemplified by AFM imaging, together with structural capsid damage. The addition of zinc sulfate to the ethanol formulation did not add the formulation efficacy, but the unexpected mechanistic synergy between NiCl2 and the ethanol formulation opens an interesting perspective for the possible potentiation of an alcohol-based formulation. Furthermore, we show that AFM can be an important tool for understanding the mechanistic impact of virucidal formulation., Reckitt Benckiser funded a PhD Studentship (LV) administered by Cardiff University. CSM and GNC were supported by grants PID2019-104098GB-I00/AEI/10.13039/501100011033 and BFU2016-74868-P, co-funded by the Spanish State Research Agency and the European Regional Development Fund, as well as BFU2013-41249-P and BIO2015-68990-REDT (the Spanish Adenovirus Network, AdenoNet) from the Spanish Ministry of Economy, Industry and Competitiveness; and the Agencia Estatal CSIC (2019AEP045). The CNB-CSIC was further supported by a Severo Ochoa Excellence grant (SEV 2017-0712). PJP acknowledges grants from the Spanish Ministry of Economy, Industry and Competitiveness projects (FIS2017- 89549-R; Maria de Maeztu Program for Units of Excellence in R&D MDM-2014-0377; and FIS2017-90701- REDT) and Human Frontiers Science Program (HFSPO RGP0012/2018).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

A Multiplex Immunosensor for Detecting Perchlorate-Reducing Bacteria for Environmental Monitoring and Planetary Exploration

  • Gallardo-Carreño, Ignacio
  • Moreno-Paz, Mercedes
  • Aguirre, Jacobo
  • Blanco, Yolanda
  • Alonso-Pintado, Eduardo
  • Raymond-Bouchard, Isabelle
  • Maggiori, Catherine
  • Rivas, Luis A.
  • Engelbrektson, Anna
  • Whyte, Lyle
  • Parro-García, Víctor
© 2020 Gallardo-Carreño, Moreno-Paz, Aguirre, Blanco, Alonso-Pintado, Raymond-Bouchard, Maggiori, Rivas, Engelbrektson, Whyte and Parro., Perchlorate anions are produced by chemical industries and are important contaminants in certain natural ecosystems. Perchlorate also occurs in some natural and uncontaminated environments such as the Atacama Desert, the high Arctic or the Antarctic Dry Valleys, and is especially abundant on the surface of Mars. As some bacterial strains are capable of using perchlorate as an electron acceptor under anaerobic conditions, their detection is relevant for environmental monitoring on Earth as well as for the search for life on Mars. We have developed an antibody microarray with 20 polyclonal antibodies to detect perchlorate-reducing bacteria (PRB) strains and two crucial and highly conserved enzymes involved in perchlorate respiration: perchlorate reductase and chlorite dismutase. We determined the cross-reactivity, the working concentration, and the limit of detection of each antibody individually and in a multiplex format by Fluorescent Sandwich Microarray Immunoassay. Although most of them exhibited relatively high sensitivity and specificity, we applied a deconvolution method based on graph theory to discriminate between specific signals and cross-reactions from related microorganisms. We validated the system by analyzing multiple bacterial isolates, crude extracts from contaminated reactors and salt-rich natural samples from the high Arctic. The PRB detecting chip (PRBCHIP) allowed us to detect and classify environmental isolates as well as to detect similar strains by using crude extracts obtained from 0.5 g even from soils with low organic-matter levels (<103 cells/g of soil). Our results demonstrated that PRBCHIP is a valuable tool for sensitive and reliable detection of perchlorate-reducing bacteria for research purposes, environmental monitoring and planetary exploration., This work was funded by the Ministry of Economy and Competitiveness, (MINECO)/Fondo Europeo de Desarrollo Regional (FEDER) grant numbers AYA2011-24803, ESP2015-69540-R, and RTI2018-094368-B-I00, and MDM-2017-0737 Unidad de Excelencia “Maria de Maeztu”, Centro de Astrobiología (INTA-CSIC). JA was supported by the Spanish MINECO project MiMevo FIS2017 89773-P and SEV 2017-0712. IG-C was a FPI program fellowship (MINECO).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Emergence of complex socioeconomic networks driven byindividual and collective interests

  • Iranzo, Jaime
  • Pablo-Martí, Federico
  • Aguirre, Jacobo
The basic mechanisms that lead to the creation of complex socioeconomic structures remain poorly understood. A combination of network science and game theory can help explain them by examining how simple networks interact to build complex entities, both when connections among individuals are exclusively guided by self-interest or when they result from a mixture of individual and collective motivations. Here we present a theoretical framework where individuals or human groups from different communities connect to each other only if they increase their own eigenvector centrality, a topological measure of wide applications in many different contexts that quantifies the importance of a node within the network. Our analytical and numerical results show that the emergence of interconnected networks is catalyzed by the self-interest of peripheral agents, who are penalized in the long run but transiently benefit from establishing links with nodes from other communities. Moreover, the interconnection process leads to a hierarchical, assortative, and very efficient structure where links across networks involve nodes of the same importance. These findings are robust to the introduction of moderate levels of collective-oriented behavior and compatible with the interconnection dynamics observed in real-world socioeconomic networks., The authors acknowledge the assistance of D. Peralta-Salas in the analytical computations, fruitful conversations with N. Aguirre, A. Alonso, S. Bowles, I. Briz Godino, P. Catalán, J. Cuesta, A. Delgado, L. Dudbridge, N. Fiorini, J.-M. Galán, O. Gómez, H. Gintis, S. Lozano, S. Manrubia, L. Prignano, F. Puente-Sánchez, A.-L. Sanz, and P. Yubero, and the support of the Spanish Ministerio de Ciencia, Innovación y Universidades under Project No. FIS2017-89773-P (MiMevo). J.A. is supported through Grant No. SEV 2017-0712 and the Spanish State Research Agency (AEI) Project No. MDM-2017-0737 Unidad de Excelencia María de Maeztu-Centro de Astrobiología (INTA-CSIC). J.I. is supported by the Ramón y Cajal Programme from the Spanish Ministry of Science (Grant No. RYC-2017-22524), the Agencia Estatal de Investigación of Spain (Grant No. PID2019-106618GA-I00), and the Severo Ochoa Programme for Centres of Excellence in R&D from the Agencia Estatal de Investigación of Spain (Grant No. SEV2016-0672 (2017–2021) to the CBGP). F.P.-M. is supported through Grants No. CSO2016-74888-C4-4-R (CITITALENT, AEI/FEDER, UE), No. H2019/HUM-5761 (INNJOBMADCM) and 2019/00003/016/001/007 (COVID-19 UAH).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

3DBionotes COVID-19 Edition

  • Macías, José Ramón
  • Sánchez-García, Rubén
  • Conesa Mingo, Pablo
  • Ramírez-Aportela, Erney
  • Martínez González, Marta
  • Wert-Carvajal, Carlos
  • Parra-Pérez, Alberto M.
  • Segura, Joan
  • Horrell, Sam
  • Thorn, Andrea
  • Sorzano, Carlos Óscar S.
  • Carazo, José M.
https://3dbionotes.cnb.csic.es/ws/covid19, The web platform 3DBionotes-WS integrates multiple Web Services and an interactive Web Viewer to provide a unified environment in which biological annotations can be analyzed in their structural context. Since the COVID-19 outbreak, new structural data from many viral proteins have been provided at a very fast pace. This effort includes many cryogenic Electron Microscopy (cryo-EM) studies, together with more traditional ones (X-rays, NMR), using several modeling approaches and complemented with structural predictions. At the same time, a plethora of new genomics and interactomics information (including fragment screening and structure-based virtual screening efforts) have been made available from different servers. In this context we have developed 3DBionotes-COVID-19 as an answer to: (1) The need to explore multi-omics data in a unified context with a special focus on structural information and (2) the drive to incorporate quality measurements, especially in the form of advanced validation metrics for cryogenic Electron Microscopy., We acknowledge financial support from: CSIC (PIE/COVID-19 number 202020E079), the Comunidad de Madrid through grant CAM (S2017/BMD-3817), the Spanish Ministry of Science and Innovation through projects (SEV 2017-0712, FPU-2015/264, PID2019-104757RB-I00 / AEI / 10.13039/501100011033), the Instituto de Salud Carlos III: PT17/0009/0010 (ISCIII-SGEFI / ERDF-) and the European Union and Horizon 2020 through grant: CORBEL (INFRADEV-01-2014- 1, Proposal 654248) and EOSC Life (INFRAEOSC-04-2018, Proposal: 824087). This work was supported by Instruct-ULTRA (Grant 731005), an EU H2020 project to further develop the services of Instruct-ERIC. Contributions from the Coronavirus Structural Task Force were supported by the German Federal Ministry of Education and Research [grant no. 05K19WWA] and Deutsche Forschungsgemeinschaft [project TH2135/2-1]. The authors acknowledge the support and the use of resources of Instruct, a Landmark ESFRI project., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

DeepEMhancer: a deep learning solution for cryo-EM volume post-processing

  • Sánchez-García, Rubén
  • Gómez-Blanco, Josué
  • Cuervo, Ana
  • Carazo, José M.
  • Sorzano, Carlos Óscar S.
  • Vargas, Javier
Versión preprint disponible en: http://hdl.handle.net/10261/214335, Cryo-EM maps are valuable sources of information for protein structure modeling. However, due to the loss of contrast at high frequencies, they generally need to be post-processed to improve their interpretability. Most popular approaches, based on global B-factor correction, suffer from limitations. For instance, they ignore the heterogeneity in the map local quality that reconstructions tend to exhibit. Aiming to overcome these problems, we present DeepEMhancer, a deep learning approach designed to perform automatic post-processing of cryo-EM maps. Trained on a dataset of pairs of experimental maps and maps sharpened using their respective atomic models, DeepEMhancer has learned how to post-process experimental maps performing masking-like and sharpening-like operations in a single step. DeepEMhancer was evaluated on a testing set of 20 different experimental maps, showing its ability to reduce noise levels and obtain more detailed versions of the experimental maps. Additionally, we illustrated the benefits of DeepEMhancer on the structure of the SARS-CoV-2 RNA polymerase., The authors would like to acknowledge economical support from: The Spanish Ministry of Science and Innovation through Grants: Proyectos de I+D+i - RTI Tipo A PID2019-108850RA-I00, SEV 2017-0712, PID2019-104757RB-I00/ AEI/10.13039/501100011033; the “Comunidad Autónoma de Madrid” through Grant S2017/BMD-3817; CSIC: PIE/COVID-19 number 202020E079; European Union (EU) and Horizon 2020 through grants EOSC Life (INFRAEOSC-04-2018, Proposal: 824087) and HighResCells (ERC - 2018- SyG, Proposal: 810057). J.V. acknowledges economical support from the Ramón y Cajal 2018 program (RYC2018-024087-I)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Otros (Other)

Vaccination strategies in structured populations under partial immunity and reinfection

  • Rodríguez Maroto, Gabriel
  • Atienza-Diez, Iker
  • Ares, Saúl
  • Manrubia Cuevas, Susanna
Optimal protocols of vaccine administration to minimize the effects of infectious diseases depend on a number of variables that admit different degrees of control. Examples include the characteristics of the disease and how it impacts on different groups of individuals as a function of sex, age or socioeconomic status, its transmission mode, or the demographic structure of the affected population. Here we introduce a compartmental model of infection propagation with vaccination and reinfection and analyse the effect that variations on the rates of these two processes have on the progression of the disease and on the number of fatalities. The population is split into two groups to highlight the overall effects on disease caused by different relationships between vaccine administration and various demographic structures. We show that optimal administration protocols depend on the vaccination rate, a variable severely conditioned by vaccine supply and acceptance. As a practical example, we study COVID-19 dynamics in various countries using real demographic data. The model can be easily applied to any other disease and demographic structure through a suitable estimation of parameter values. Simulations of the general model can be carried out at the interactive webpage https://mybinder.org/v2/gh/IkerAtienza/SIYRD/main?urlpath=\%2Fvoila\%2Frender\%2FSimulator.ipynb, The authors are indebted to A. Vespignani for support with the use of their data. Grants PID2020-113284GB-C21 (I.A., S.M.) and BADS (PID2019-109320GB-100, S.A.) funded by MCIN/AEI/10.13039/501100011033. The Spanish MICINN has also funded the “Severo Ochoa” Centers of Excellence to CNB, SEV 2017-0712, and the special grant PIE 2020-20E079 (CNB) entitled “Development of protection strategies against SARS-CoV-2”., No
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Otros (Other)

The structural role of SARS-CoV-2 genetic background in the emergence and success of spike mutations: the case of the spike A222V mutation

  • Ginex, Tiziana
  • Marco-Marín, Clara
  • Wieczor, Milosz
  • Mata, Carlos P.
  • Krieger, James
  • López-Redondo, Marisa
  • Francés-Gómez, Clara
  • Ruiz-Rodríguez, Paula
  • Melero, Roberto
  • Sorzano, Carlos Óscar S.
  • Martínez, Marta
  • Gougeard, Nadine
  • Forcada-Nadal, Alicia
  • Zamora-Caballero, Sara
  • Gozalbo-Rovira, Roberto
  • Sanz-Frasquet, Carla
  • Bravo, Jerónimo
  • Rubio, Vicente
  • Marina, Alberto
  • Geller, Ron
  • Comas, Iñaki
  • Gil, Carmen
  • Coscollá, Mireia
  • Orozco, Modesto
  • Llácer, José Luis
  • Carazo, José M.
The S:A222V point mutation, within the G clade, was characteristic of the 20E (EU1) SARS-CoV-2 variant identified in Spain in early summer 2020. This mutation has now reappeared in the Delta subvariant AY.4.2, raising questions about its specific effect on viral infection. We report combined serological, functional, structural and computational studies characterizing the impact of this mutation. Our results reveal that S:A222V promotes an increased RBD opening and slightly increases ACE2 binding as compared to the parent S:D614G clade. Finally, S:A222V does not reduce sera neutralization capacity, suggesting it does not affect vaccine effectiveness., This research work was supported by the European Commission–NextGenerationEU through the CSIC Global Health Platform. Additionally, authors would like to acknowledge economic support from the Spanish Ministry of Science and Innovation through Grants: PID2019-104757RB-I00 funded by MCIN/AEI/ 10.13039/501100011033, RTI2018-094399-A-I00, and “ERDF A way of making Europe”, by the “European Union”, Grant SEV 2017-0712 funded by MCIN/AEI /10.13039/501100011033, the “Comunidad Autónoma de Madrid" through Grant: S2017/BMD3817, and the European Union (EU) and Horizon 2020 through grants: Marie-Curie Fellowship EnLaCES (MSCA IF 2020, Proposal: 101024130) (to JK), HighResCells (ERC - 2018 - SyG, Proposal: 810057), and iNEXT-Discovery (Proposal: 871037). AM, VR, JB and JLL are funded by CIBERER-ISCIII (proposal: COV20/00437), Fondo Supera COVID-19 (proposal: CSICCOVID19-082), Banco Santander (Proposal: BlockAce), and CSIC PTI Salud Global (Proposal: 202080E110). VR is funded by the Spanish Ministry of Science and Innovation through Grant PID2020-120322RB-C21. IC is funded by project PID2019-104477RB-100, Fondo COVID COV20/00140 and ERC CoG 101001038. MC is funded by the RyC program from the Spanish Ministry of Science and Innovation, the Generalitat Valenciana (SEJI/2019/011)., No
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

From genotypes to organisms: State-of-the-art and perspectives of a cornerstone in evolutionary dynamics

  • Manrubia Cuevas, Susanna
  • Cuesta, José A.
  • Aguirre, Jacobo
  • Ahnert, Sebastian E.
  • Altenberg, Lee
  • Cano, Alejandro V.
  • Catalán, Pablo
  • Díaz-Uriarte, Ramón
  • Elena, Santiago F.
  • García-Martín, Juan A.
  • Hogeweg, Paulien
  • Khatri, Bhavin S.
  • Krug, Joachim
  • Louis, Ard A.
  • Martin, Nora S.
  • Payne, Joshua L.
  • Tarnowski, Matthew J.
  • Weiß, Marcel
Referred to by: David M. McCandlish; System-specificity of genotype-phenotype map structure; Physics of Life Reviews, Volume 39, December 2021, Pages 73-75.-- Michael Manhart, Sebastian Bonhoeffer; The search for universality in evolutionary landscapes; Physics of Life Reviews, Volume 39, December 2021, Pages 76-78.-- Nitash C G, Christoph Adami; Information-theoretic characterization of the complete genotype-phenotype map of a complex pre-biotic world; Physics of Life Reviews, Volume 38, September 2021, Pages 111-114., Understanding how genotypes map onto phenotypes, fitness, and eventually organisms is arguably the next major missing piece in a fully predictive theory of evolution. We refer to this generally as the problem of the genotype-phenotype map. Though we are still far from achieving a complete picture of these relationships, our current understanding of simpler questions, such as the structure induced in the space of genotypes by sequences mapped to molecular structures, has revealed important facts that deeply affect the dynamical description of evolutionary processes. Empirical evidence supporting the fundamental relevance of features such as phenotypic bias is mounting as well, while the synthesis of conceptual and experimental progress leads to questioning current assumptions on the nature of evolutionary dynamics—cancer progression models or synthetic biology approaches being notable examples. This work delves with a critical and constructive attitude into our current knowledge of how genotypes map onto molecular phenotypes and organismal functions, and discusses theoretical and empirical avenues to broaden and improve this comprehension. As a final goal, this community should aim at deriving an updated picture of evolutionary processes soundly relying on the structural properties of genotype spaces, as revealed by modern techniques of molecular and functional analysis., SM: grant FIS2017-89773-P (MINECO/FEDER, EU); “Severo Ochoa” Centers of Excellence to CNB, SEV 2017-0712. JAC: grants FIS2015-64349-P (MINECO/FEDER, EU) and PGC2018-098186-B-I00 (MICINN/FEDER, EU). JA: grant FIS2017-89773-P (MINECO/FEDER, EU); “Severo Ochoa” Centers of Excellence to CNB, SEV 2017-0712. SEA: the Gatsby Charitable Foundation. LA: Foundational Questions Institute (FQXi) and Fetzer Franklin Fund, a donor advised fund of Silicon Valley Community Foundation, for FQXi Grant number FQXi-RFP-IPW-1913, Stanford Center for Computational, Evolutionary and Human Genomics and the Morrison Institute for Population and Resources Studies, Stanford University, the 2015 Information Processing in Cells and Tissues Conference, and the Mathematical Biosciences Institute at The Ohio State University, for its support through National Science Foundation Award #DMS 0931642. PC: Ramón Areces Postdoctoral Fellowship. RDU: grant BFU2015-67302-R (MINECO/FEDER, EU). SFE: grants BFU2015-65037-P (MCIU-FEDER) and PROMETEOII/2014/012 (Generalitat Valenciana). JK: DFG within CRC1310 “Predictability in Evolution”. NSM: Gates Cambridge Scholarship; Winton Programme for the Physics of Sustainability. JLP: Swiss National Science Foundation, grant PP00P3_170604. MJT: grants EP/L016494/1 (EPSRC/BBSRC Centre for Doctoral Training in Synthetic Biology) and BB/L01386X/1 (BBSRC/EPSRC Synthetic Biology Research Centre, BrisSynBio). MW: the EPSRC and the Gatsby Charitable Foundation., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

The structural role of SARS-CoV-2 genetic background in the emergence and success of spike mutations: The case of the spike A222V mutation

  • Ginex, Tiziana
  • Marco-Marín, Clara
  • Wieczor, Milosz
  • Mata, Carlos P.
  • Krieger, James
  • Ruiz-Rodríguez, Paula
  • López-Redondo, Marisa
  • Francés-Gómez, Clara
  • Melero, Roberto
  • Sorzano, Carlos Óscar S.
  • Martínez, Marta
  • Gougeard, Nadine
  • Forcada-Nadal, Alicia
  • Zamora-Caballero, Sara
  • Gozalbo-Rovira, Roberto
  • Sanz-Frasquet, Carla
  • Arranz, Rocío
  • Bravo, Jerónimo
  • Rubio, Vicente
  • Marina, Alberto
  • The IBV-Covid19-Pipeline Consortium
  • Geller, Ron
  • Comas, Iñaki
  • Gil, Carmen
  • Coscollá, Mireia
  • Orozco, Modesto
  • Llácer, José Luis
  • Carazo, José M.
The S:A222V point mutation, within the G clade, was characteristic of the 20E (EU1) SARS-CoV-2 variant identified in Spain in early summer 2020. This mutation has since reappeared in the Delta subvariant AY.4.2, raising questions about its specific effect on viral infection. We report combined serological, functional, structural and computational studies characterizing the impact of this mutation. Our results reveal that S:A222V promotes an increased RBD opening and slightly increases ACE2 binding as compared to the parent S:D614G clade. Finally, S:A222V does not reduce sera neutralization capacity, suggesting it does not affect vaccine effectiveness., In this research work, PRR and TG were supported by salaries from the European Commission–NextGenerationEU through the CSIC Global Health Platform established by EU Council Regulation 2020/2094. The authors would like to acknowledge economic support from: (a) the Spanish Ministry of Science and Innovation through grants: SEV-2017-0712 funded by MCIN/AEI/10.13039/501100011033 (CPM, JK, RM, COSS, MM, RA, JMC); 116880GB-I00 (JLL) and 120322RB-C21 (VR) funded within PID 2020; PID2019-104757RB-I00 funded by MCIN/AEI/10.13039/501100011033/ and “ERDF A way of making Europe”, by the “European Union” (JMC, COSS, RM, MM, CPM) and 104477RB-100 (IC) funded within PID 2019; RYC-2015-18213 (salary of MC) and RYC-2015-17517 (salary of RG) funded by the Ramon y Cajal fellowship program; RTI2018-094399-A-I00 (JMC, COSS, RM, CPM, MC) funded within the Retos Investigación program; the CRIOMECORR project funded as ESFRI-2019-01-CSIC-16; (b) the Horizon 2020 program through Marie Skłodowska-Curie Individual Fellowships EnLaCES (Proposal 101024130, salary of JK) and EPIDNA (Grant ID: 894498, salary of MW); (c) the European Research Council (ERC) through grants: ERC-2018-SyG-810057 HighResCells funded within the EXCELLENT SCIENCE program (JMC, MM, COSS, salary of RM), Grant 871037 iNEXT DISCOVERY (JMC, MM, COSS) and grant CoG-101001038 funded within the Consolidator Grants program (IC); (d) Generalitat Valenciana through grants: SEJI/2019/011 (MC) and SEJI/2019/030 (JLL); (e) Comunidad de Madrid through grant: S2017/BMD-3817 (JMC); (f) Santander Bank through grant: CSIC-COVID19-082 (AM, VR, JB, JLL, RG) funded through the Fondo Supera Covid-19; (g) Instituto de Salud Carlos III through grants: COV20/00437 (AM, VR, JB, JLL) and COV20/00140 (IC), both funded through the Fondos Covid-19 initiative; (h) Spanish National Research Council through grant: 202080E110 funded within the PTI Salud Global initiative (AM, VR, JB, JLL, RG)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Standing Genetic Diversity and Transmission Bottleneck Size Drive Adaptation in Bacteriophage Qβ

  • Somovilla, Pilar
  • Rodríguez Moreno, Alicia
  • Arribas, María
  • Manrubia Cuevas, Susanna
  • Lázaro, Ester
A critical issue to understanding how populations adapt to new selective pressures is the relative contribution of the initial standing genetic diversity versus that generated de novo. RNA viruses are an excellent model to study this question, as they form highly heterogeneous populations whose genetic diversity can be modulated by factors such as the number of generations, the size of population bottlenecks, or exposure to new environment conditions. In this work, we propagated at nonoptimal temperature (43 °C) two bacteriophage Qβ populations differing in their degree of heterogeneity. Deep sequencing analysis showed that, prior to the temperature change, the most heterogeneous population contained some low-frequency mutations that had previously been detected in the consensus sequences of other Qβ populations adapted to 43 °C. Evolved populations with origin in this ancestor reached similar growth rates, but the adaptive pathways depended on the frequency of these standing mutations and the transmission bottleneck size. In contrast, the growth rate achieved by populations with origin in the less heterogeneous ancestor did depend on the transmission bottleneck size. The conclusion is that viral diversification in a particular environment may lead to the emergence of mutants capable of accelerating adaptation when the environment changes., This research was funded by grants no. PID2020-113284GB-C21, PID2020-113284GB-C22, MDM-2017-0737 Unidad de Excelencia “María de Maeztu”-Centro de Astrobiología (CSIC-INTA), SEV 2017-0712 “Severo Ochoa” Centers of Excellence (CNB) given by the Spanish Ministry of Science and Innovation, the State Agency of Research (MCIN/AEI/10.13039/501100011033), and by “ERDF A way of making Europe”., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (MDM-2017-0737) (SEV 2017-0712), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Targeted Proteomics for Monitoring One-Carbon Metabolism in Liver Diseases

  • Guerrero, Laura
  • Paradela, Alberto
  • Corrales, Fernando J.
Liver diseases cause approximately 2 million deaths per year worldwide and had an increasing incidence during the last decade. Risk factors for liver diseases include alcohol consumption, obesity, diabetes, the intake of hepatotoxic substances like aflatoxin, viral infection, and genetic determinants. Liver cancer is the sixth most prevalent cancer and the third in mortality (second in males). The low survival rate (less than 20% in 5 years) is partially explained by the late diagnosis, which remarks the need for new early molecular biomarkers. One-carbon metabolism integrates folate and methionine cycles and participates in essential cell processes such as redox homeostasis maintenance and the regulation of methylation reactions through the production of intermediate metabolites such as cysteine and S-Adenosylmethionine. One-carbon metabolism has a tissue specific configuration, and in the liver, the participating enzymes are abundantly expressed—a requirement to maintain hepatocyte differentiation. Targeted proteomics studies have revealed significant differences in hepatocellular carcinoma and cirrhosis, suggesting that monitoring one-carbon metabolism enzymes can be useful for stratification of liver disease patients and to develop precision medicine strategies for their clinical management. Here, reprogramming of one-carbon metabolism in liver diseases is described and the role of mass spectrometry to follow-up these alterations is discussed., The CNB was supported by Comunidad de Madrid Grant B2017/BMD-3817. Severo Ochoa Project SEV 2017-0712. Intramural CSIC PIE/COVID-19 projects 202020E079 and 202020E108. This research work was also funded by the European Commission—NextGenerationEU (Regulation EU 2020/2094), through CSIC’s Global Health Platform (PTI Salud Global)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Spatial control of potato tuberization by the TCP transcription factor BRANCHED1b

  • Nicolas, Michael
  • Torres-Pérez, Rafael
  • Wahl, Vanessa
  • Cruz-Oró, Eduard
  • Rodríguez Buey, María
  • Zamarreño, Angel María
  • Martín-Jouve, Beatriz
  • García-Mina, José María
  • Oliveros, Juan C.
  • Prat, Salomé
  • Cubas, Pilar
The control of carbon allocation, storage and usage is critical for plant growth and development and is exploited for both crop food production and CO2 capture. Potato tubers are natural carbon reserves in the form of starch that have evolved to allow propagation and survival over winter. They form from stolons, below ground, where they are protected from adverse environmental conditions and animal foraging. We show that BRANCHED1b (BRC1b) acts as a tuberization repressor in aerial axillary buds, which prevents buds from competing in sink strength with stolons. BRC1b loss of function leads to ectopic production of aerial tubers and reduced underground tuberization. In aerial axillary buds, BRC1b promotes dormancy, abscisic acid responses and a reduced number of plasmodesmata. This limits sucrose accumulation and access of the tuberigen protein SP6A. BRC1b also directly interacts with SP6A and blocks its tuber-inducing activity in aerial nodes. Altogether, these actions help promote tuberization underground., The work of P.C. was funded by BIO2014-57011-R (MINECO), BIO2017-84363-R (Spanish Ministry of Science and Innovation) (MCIN/AEI/10.13039/501100011033/) and FESF investing in your future. The work of S.P. was funded by BIO2015-73019-EXP (Spanish Ministry of Science and Innovation) (MCIN/AEI/10.13039/501100011033/), ERA-NET COSMIC EIG CONCERT-Japan (PCIN-2017-032) (Spanish Ministry of Science and Innovation) and European Union H2020 ‘ADAPT’ project. The work of R.T.-P. and J.C.O. was funded by CSIC-202020E079 (Spanish National Research Council). The work of V.W. was funded by BMBF (031B0191), DFG (SPP1530: WA3639/1-2, 2-1) and Max-Planck-Society. M.N. had an Excellence Severo Ochoa contract (MINECO, SEV-2013-0347). The CNB is a Severo Ochoa Center of Excellence (MINECO award SEV 2017-0712)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

COP1 dynamics integrate conflicting seasonal light and thermal cues in the control of Arabidopsis elongation

  • Nieto García, Cristina
  • Catalán, Pablo
  • Luengo, Luis Miguel
  • Legris, Martina
  • López-Salmerón, Vadir
  • Davière, Jean Michel
  • Casal, Jorge J.
  • Ares, Saúl
  • Prat, Salomé
Centro de Recursos Fitogenéticos y Agricultura Sostenible (CRF)., As the summer approaches, plants experience enhanced light inputs and warm temperatures, two environmental cues with an opposite morphogenic impact. Key components of this response are PHYTOCHROME B (phyB), EARLY FLOWERING 3 (ELF3), and CONSTITUTIVE PHOTOMORPHOGENIC 1 (COP1). Here, we used single and double mutant/overexpression lines to fit a mathematical model incorporating known interactions of these regulators. The fitted model recapitulates thermal growth of all lines used and correctly predicts thermal behavior of others not used in the fit. While thermal COP1 function is accepted to be independent of diurnal timing, our model shows that it acts at temperature signaling only during daytime. Defective response of cop1-4 mutants is epistatic to phyB-9 and elf3-8, indicating that COP1 activity is essential to transduce phyB and ELF3 thermosensory function. Our thermal model provides a unique toolbox to identify best allelic combinations enhancing climate change resilience of crops adapted to different latitudes., Research has been supported by Spanish MCIN/AEI/10.13039/501100011033/ and FEDER Una manera de hacer Europa (grant nos. PGC2018-098186-B-100 to P.C., FIS2016-78313-P to S.A., and BIO2017-90056-R/PID2020-119758RB-I00 to S.P.), besides grant BADS, no. PID2019-109320GB-100, to S.A. and P.C, and funding from University of Buenos Aires (grant no. 20020170100505BA to J.J.C.), and Agencia Nacional de Promoción Científica y Tecnológica (grant no. PICT-2019-2019-01354 to J.J.C.). The CNB and CRAG Institutes also received the “Severo Ochoa” Centers of Excellence SEV 2017-0712 (CNB) and CEX2019-000902-S (CRAG) awards from the Spanish Ministerio de Ciencia e Innovación., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Otros (Other)

Vaccination strategies in structured populations under partial immunity and reinfection

  • Rodríguez Maroto, Gabriel
  • Atienza-Diez, Iker
  • Ares, Saúl
  • Manrubia Cuevas, Susanna
Optimal protocols of vaccine administration to minimize the effects of infectiousdiseases depend on a number of variables that admit different degrees of control.Examples include the characteristics of the disease and how it impacts on differentgroups of individuals as a function of sex, age or socioeconomic status, its transmissionmode, or the demographic structure of the affected population. Here we introduce acompartmental model of infection propagation with vaccination and reinfection andanalyse the effect that variations on the rates of these two processes have on theprogression of the disease and on the number of fatalities. The population is split intotwo groups to highlight the overall effects on disease caused by different relationshipsbetween vaccine administration and various demographic structures. As a practicalexample, we study COVID-19 dynamics in various countries using real demographicdata. The model can be easily applied to any other disease and demographic structurethrough a suitable estimation of parameter values. Two main conclusions stand out.First, the higher the fraction of reinfected individuals, the higher the likelihood that thedisease becomes quasi-endemic. Second, optimal vaccine roll-out depends ondemographic structure and disease fatality, so there is no unique vaccination protocol,valid for all countries, that minimizes the effects of a specific disease. Simulations of thegeneral model can be carried out at this interactive webpage, The authors are indebted to A. Vespignani for support with the use of their data. 461 Grants PID2020-113284GB-C21 (I.A., S.M.) and BADS (PID2019-109320GB-100, S.A.) 462 funded by MCIN/AEI/10.13039/501100011033. The Spanish MICINN has also funded 463 the “Severo Ochoa” Centers of Excellence to CNB, SEV 2017-0712, and the special 464 grant PIE 2020-20E079 (CNB) entitled “Development of protection strategies against 465 SARS-CoV-2”., No
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Mapping the Serum Proteome of COVID-19 Patients; Guidance for Severity Assessment

  • Núñez, Estefanía
  • Orera Utrilla, Irene
  • Carmona-Rodríguez, Lorena
  • Paño, José Ramón
  • Vázquez, Jesús
  • Corrales, Fernando J.
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), whose outbreak in 2019 led to an ongoing pandemic with devastating consequences for the global economy and human health. According to the World Health Organization, COVID-19 has affected more than 481 million people worldwide, with 6 million confirmed deaths. The joint efforts of the scientific community have undoubtedly increased the pace of production of COVID-19 vaccines, but there is still so much uncharted ground to cover regarding the mechanisms of SARS-CoV-2 infection, replication and host response. These issues can be approached by proteomics with unprecedented capacity paving the way for the development of more efficient strategies for patient care. In this study, we present a deep proteome analysis that has been performed on a cohort of 72 COVID-19 patients aiming to identify serum proteins assessing the dynamics of the disease at different age ranges. A panel of 53 proteins that participate in several functions such as acute-phase response and inflammation, blood coagulation, cell adhesion, complement cascade, endocytosis, immune response, oxidative stress and tissue injury, have been correlated with patient severity, suggesting a molecular basis for their clinical stratification. Eighteen protein candidates were further validated by targeted proteomics in an independent cohort of 84 patients including a group of individuals that had satisfactorily resolved SARS-CoV-2 infection. Remarkably, all protein alterations were normalized 100 days after leaving the hospital, which further supports the reliability of the selected proteins as hallmarks of COVID-19 progression and grading. The optimized protein panel may prove its value for optimal severity assessment as well as in the follow up of COVID-19 patients., This study was supported by competitive grants from the Spanish Ministry of Science, Innovation and Universities (PGC2018-097019-B-I00), the Instituto de Salud Carlos III (Fondo de Investigación Sanitaria grant PRB3 (PT17/0019/0003-ISCIII-SGEFI/ERDF, ProteoRed), and “la Caixa” Banking Foundation (project code HR17-00247). The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the Ministerio de Ciencia e Innovación (MCIN) and the Pro CNIC Foundation), and is a Severo Ochoa Center of Excellence (grant CEX2020-001041-S funded by MICIN/AEI/10.13039/501100011033). The CNB was supported by the Carlos III Health Institute of Spain -Fondos FEDER (EU) (PRB3-ISCIII, supported by grant PT17/0019/0001). Comunidad de Madrid Grant B2017/BMD-3817. Severo Ochoa Project SEV 2017-0712. Intramural CSIC PIE/COVID-19 projects 202020E079 and 202020E108. This research work was also funded by the European Commission—NextGenerationEU (Regulation EU 2020/2094), through CSIC’s Global Health Platform (PTI Salud Global)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Full protection from SARS-CoV-2 brain infection and damage in susceptible transgenic mice conferred by MVA-CoV2-S vaccine candidate

  • Villadiego, Javier
  • García-Arriaza, Juan
  • Ramírez Lorca, Reposo
  • García-Swinburn, Roberto
  • Cabello-Rivera, Daniel
  • Rosales-Nieves, Alicia E.
  • Álvarez-Vergara, María I.
  • Cala-Fernández, Fernando
  • García-Roldán, Ernesto
  • López-Ogáyar, Juan L.
  • Zamora, Carmen
  • Astorgano, David
  • Albericio, Guillermo
  • Pérez Ramírez, Patricia
  • Muñoz-Cabello, Ana M.
  • Pascual Bravo, Alberto
  • Esteban, Mariano
  • López-Barneo, José
  • Toledo-Aral, Juan José
Vaccines against SARS-CoV-2 have been shown to be safe and effective but their protective efficacy against infection in the brain is yet unclear. Here, in the susceptible transgenic K18-hACE2 mouse model of severe coronavirus disease 2019 (COVID-19), we report a spatiotemporal description of SARS-CoV-2 infection and replication through the brain. SARS-CoV-2 brain replication occurs primarily in neurons, leading to neuronal loss, signs of glial activation and vascular damage in mice infected with SARS-CoV-2. One or two doses of a modified vaccinia virus Ankara (MVA) vector expressing the SARS-CoV-2 spike (S) protein (MVA-CoV2-S) conferred full protection against SARS-CoV-2 cerebral infection, preventing virus replication in all areas of the brain and its associated damage. This protection was maintained even after SARS-CoV-2 reinfection. These findings further support the use of MVA-CoV2-S as a promising vaccine candidate against SARS-CoV-2/COVID-19., We thank the CSIC and the Spanish Ministry of Science and Innovation for continuous support. This research was supported by the Spanish Ministry of Science and Innovation/Spanish Research Agency/10.13039/501100011033 grant nos. PID2019-105995RB-I00 (J.J.T.-A. and J.V.), PID2020-114481RB-I00 (J.G.-A. and M.E.), RTI2018-096629-B-I00 (A.P.) and PID2019-106410RB-I00 (J.L.-B.). Moreover, this research was also funded by Red TerCel ISCIII (no. RD16/0011/0025 to J.J.T.-A.), Consejería de Economía, Conocimiento, Empresas y Universidad US-1380891 (to J.J.T.-A. and J.V.), Consejería de Salud y Familias, Junta de Andalucía grant no. PECOVID-0078-2020 (to R.R.-L. and J.V.), Consejería de Educación y Deporte, Junta de Andalucía grant no. PY20_01312 (to A.P.), Fondo COVID-19 grant no. COV20/00151 (Spanish Health Ministry, Instituto de Salud Carlos III), Fondo Supera COVID-19 (Crue Universidades-Banco Santander) grant and CSIC grant no. 202120E079 (J.G.-A.), CSIC grant no. 2020E84, La CaixaImpulse grant no. CF01-00008 and Ferrovial and MAPFRE donations (to M.E.). Additionally, we received funding from the European Commission-NextGenerationEU, through the CSIC’s Global Health Platform (PTI Salud Global) (to J.G.-A. and M.E.) and the European Research Council (ERC Advanced grant no. PRJ201502629) (to J.L.-B.). J.G.-A. and M.E. also acknowledge financial support from the Spanish State Research Agency (no. AEI/10.13039/501100011033) through the ‘Severo Ochoa’ Programme for Centres of Excellence in R&D (nos. SEV-2013-0347 and SEV-2017-0712). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Serum angiotensin-converting enzyme 2 as a potential biomarker for SARS-CoV-2 infection and vaccine efficacy

  • Lennol, Matthew P.
  • García-Ayllón, María-Salud
  • Esteban, Mariano
  • García-Arriaza, Juan
  • Sáez-Valero, Javier
Various species of the SARS-CoV-2 host cell receptor, the angiotensin-converting enzyme 2 (ACE2), are present in serum, which may result from virus entry and subsequent proteolytic processing of the membrane receptor. We have recently demonstrated changes of particular ACE2 species in virus infected humans, either cleaved fragments or circulating full-length species. Here, we further explore the potential of serum ACE2 as a biomarker to test SARS-CoV-2 infection and vaccine efficacy in virus susceptible transgenic K18-hACE2 mice expressing human ACE2. First, in serum samples derived from K18-hACE2 mice challenged with a lethal dose of SARS-CoV-2, we observed an increase in the levels of cleaved ACE2 fragment at day 2 post-challenge, which may represent the subsequent proteolytic processing through virus entry. These elevated levels were maintained until the death of the animals at day 6 post-challenge. The circulating full-length ACE2 form displayed a sizable peak at day 4, which declined at day 6 post-challenge. Noticeably, immunization with two doses of the MVA-CoV2-S vaccine candidate prevented ACE2 cleaved changes in serum of animals challenged with a lethal dose of SARS-CoV-2. The efficacy of the MVA-CoV2-S was extended to vaccinated mice after virus re-challenge. These findings highlight that ACE2 could be a potential serum biomarker for disease progression and vaccination against SARS-CoV-2., This study was funded in part by the Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL; grant 2020-0308), the Direcció General de Ciència I Investigació, Generalitat Valenciana (AICO/2021/308), and by the Instituto de Salud Carlos III (ISCIII, grants PI19-01359), co-financed by the Fondo Europeo de Desarrollo Regional (FEDER, “Investing in your future”) and through CIBERNED, ISCIII. We also acknowledge financial support from the Spanish Ministerio de Economía y Competitividad, through the “Severo Ochoa” Programme for Centres of Excellence in R&D (SEV-2017-0723). This research was also supported by Fondo COVID-19 grant COV20/00151 (Spanish Health Ministry, Instituto de Salud Carlos III (ISCIII)), Fondo Supera COVID-19 grant (Crue Universidades-Banco Santander), and Spanish Research Council (CSIC) grant 202120E079 (to JG-A); CSIC grant 2020E84, Ferrovial, and MAPFRE donations (to ME); and Spanish Ministry of Science and Innovation (MCIN)/Spanish Research Agency (AEI)/10.13039/501100011033 grant (PID2020-114481RB-I00; to JG-A and ME). This research work was also funded by the European Commission- NextGenerationEU, through CSIC’s Global Health Platform (PTI Salud Global) (to JG-A and ME). MPL is supported by a BEFPI scholarship from the Generalitat Valenciana. JGA and ME acknowledges financial support from the Spanish State Research Agency, AEI/10.13039/501100011033, through the “Severo Ochoa” Programme for Centres of Excellence in R&D (SEV-2013-0347, SEV-2017-0712)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Enhanced cross-recognition of SARS-CoV-2 Omicron variant by peptide vaccine-induced antibodies

  • Aparicio, Belén
  • Ruiz, Marta
  • Casares, Noelia
  • Silva, Leyre
  • Egea, Josune
  • Pérez Ramírez, Patricia
  • Albericio, Guillermo
  • Esteban, Mariano
  • García-Arriaza, Juan
  • Lasarte, Juan José
  • Sarobe, Pablo
Current vaccines against SARS-CoV-2, based on the original Wuhan sequence, induce antibodies with different degrees of cross-recognition of new viral variants of concern. Despite potent responses generated in vaccinated and infected individuals, the Omicron (B.1.1.529) variant causes breakthrough infections, facilitating viral transmission. We previously reported a vaccine based on a cyclic peptide containing the 446-488 S1 sequence (446-488cc) of the SARS-CoV-2 spike (S) protein from Wuhan isolate. To provide the best immunity against Omicron, here we compared Omicron-specific immunity induced by a Wuhanbased 446-488cc peptide, by a Wuhan-based recombinant receptor-binding domain (RBD) vaccine and by a new 446-488cc peptide vaccine based on the Omicron sequence. Antibodies induced by Wuhan peptide 446-488cc in three murine strains not only recognized the Wuhan and Omicron 446-488 peptides similarly, but also Wuhan and Omicron RBD protein variants. By contrast, antibodies induced by the Wuhan recombinant RBD vaccine showed a much poorer cross-reactivity for the Omicron RBD despite similar recognition of Wuhan and Omicron peptide variants. Finally, although the Omicron-based 446-488cc peptide vaccine was poorly immunogenic in mice due to the loss of T cell epitopes, co-immunization with Omicron peptide 446-488cc and exogenous T cell epitopes induced strong cross-reactive antibodies that neutralized Omicron SARS-CoV-2 virus. Since mutations occurring within this sequence do not alter T cell epitopes in humans, these results indicate the robust immunogenicity of 446-488cc-based peptide vaccines that induce antibodies with a high crossrecognition capacity against Omicron, and suggest that this sequence could be included in future vaccines targeting the Omicron variant., This work was supported by Instituto de Salud Carlos III, Fondo Europeo de Desarrollo Regional “Una manera de hacer Europa” under grant PI20/00260, Gobierno de Navarra under grant 0011- 3597-2020-000024 to PS and by Paula & Rodger Riney Foundation to JJL. This research was also supported by Spanish Research Council (CSIC) grants 202120E079 (to JG-A) and 2020E84 (to ME), Spanish Ministry of Science and Innovation (MCIN)/Spanish Research Agency (AEI)/10.13039/501100011033 grant (PID2020-114481RBI00; to JG-A and ME), and Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC) co-financed with FEDER funds (to JG-A). This research work was also funded by the European Commission-NextGenerationEU, through CSIC’s Global Health Platform (PTI Salud Global) (to JG-A and ME). JG-A and ME also acknowledge financial support from the Spanish State Research Agency, AEI/10.13039/501100011033, through the “Severo Ochoa” Programme for Centres of Excellence in R&D (SEV-2013-0347, SEV- 2017-0712)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Truncation-Driven Lateral Association of α-Synuclein Hinders Amyloid Clearance by the Hsp70-Based Disaggregase

  • Franco, Aitor
  • Cuéllar, Jorge
  • Fernández-Higuero, José Ángel
  • Arada, Igor de la
  • Orozco, Natalia
  • Valpuesta, José M.
  • Prado, Adelina
  • Muga, Arturo
The aggregation of α-synuclein is the hallmark of a collective of neurodegenerative disorders known as synucleinopathies. The tendency to aggregate of this protein, the toxicity of its aggregation intermediates and the ability of the cellular protein quality control system to clear these intermediates seems to be regulated, among other factors, by post-translational modifications (PTMs). Among these modifications, we consider herein proteolysis at both the N- and C-terminal regions of α-synuclein as a factor that could modulate disassembly of toxic amyloids by the human disaggregase, a combination of the chaperones Hsc70, DnaJB1 and Apg2. We find that, in contrast to aggregates of the protein lacking the N-terminus, which can be solubilized as efficiently as those of the WT protein, the deletion of the C-terminal domain, either in a recombinant context or as a consequence of calpain treatment, impaired Hsc70-mediated amyloid disassembly. Progressive removal of the negative charges at the C-terminal region induces lateral association of fibrils and type B* oligomers, precluding chaperone action. We propose that truncation-driven aggregate clumping impairs the mechanical action of chaperones, which includes fast protofilament unzipping coupled to depolymerization. Inhibition of the chaperone-mediated clearance of C-truncated species could explain their exacerbated toxicity and higher propensity to deposit found in vivo., This work was supported by grants PID2019-111068GB-I00 (to A.M.) (AEI/FEDER, UE) and PID2019-105872GB-I00 (to J.M.V.) (AEI/FEDER, UE) from the Ministry of Science and Innovation and by the Basque Government (grant IT1201-19 to AM). The Centro Nacional de Biotecnología (CNB) is a Severo Ochoa Center of Excellence (MINECO award SEV 2017-0712)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Research data Set de datos (Dataset)

Supplementary Materials for COP1 dynamics integrate conflicting seasonal light and thermal cues in the control of Arabidopsis elongation

  • Nieto García, Cristina
  • Catalán, Pablo
  • Luengo, Luis Miguel
  • Legris, Martina
  • López-Salmerón, Vadir
  • Davière, Jean Michel
  • Casal, Jorge J.
  • Ares, Saúl
  • Prat, Salomé
39 pages. -- This PDF file includes: Figs. S1 to S16. -- Supplementary Text. -- Tables S1 to S6. -- References., The CNB and CRAG Institutes also received the “Severo Ochoa” Centers of Excellence SEV 2017-0712 (CNB) and CEX2019-000902-S (CRAG) awards from the Spanish Ministerio de Ciencia e Innovación., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2019-000902-S), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Selective Pressure by Rifampicin Modulates Mutation Rates and Evolutionary Trajectories of Mycobacterial Genomes

  • Cebrián-Sastre, E.
  • Chiner-Oms, Álvaro
  • Torres-Pérez, Rafael
  • Comas, Iñaki
  • Oliveros, Juan C.
  • Blázquez, J.
  • Castañeda-García, Alfredo
20 páginas, 8 figuras, 2 tablas. Material suplementario accesible solo online, Resistance to the frontline antibiotic rifampicin constitutes a challenge to the treatment and control of tuberculosis. Here, we analyzed the mutational landscape of Mycobacterium smegmatis during long-term evolution with increasing concentrations of rifampicin, using a mutation accumulation assay combined with whole-genome sequencing. Antibiotic treatment enhanced the acquisition of mutations, doubling the genome-wide mutation rate of the wild-type cells. While antibiotic exposure led to extinction of almost all wild-type lines, the hypermutable phenotype of the ΔnucS mutant strain (noncanonical mismatch repair deficient) provided an efficient response to the antibiotic, leading to high rates of survival. This adaptative advantage resulted in the emergence of higher levels of rifampicin resistance, an accelerated acquisition of drug resistance mutations in rpoB (β RNA polymerase), and a wider diversity of evolutionary pathways that led to drug resistance. Finally, this approach revealed a subset of adaptive genes under positive selection with rifampicin that could be associated with the development of antibiotic resistance. IMPORTANCE Rifampicin is the most important first-line antibiotic against mycobacterial infections, including tuberculosis, one of the top causes of death worldwide. Acquisition of rifampicin resistance constitutes a major global public health problem that makes the control of the disease challenging. Here, we performed an experimental evolution assay under antibiotic selection to analyze the response and adaptation of mycobacteria, leading to the acquisition of rifampicin resistance. This approach explored the total number of mutations that arose in the mycobacterial genomes under long-term rifampicin exposure, using whole-genome sequencing. Our results revealed the effect of rifampicin at a genomic level, identifying different mechanisms and multiple pathways leading to rifampicin resistance in mycobacteria. Moreover, this study detected that an increase in the rate of mutations led to enhanced levels of drug resistance and survival. In summary, all of these results could be useful to understand and prevent the emergence of drug-resistant isolates in mycobacterial infections., This research was funded by MCIN/AEI/10.13039/501100011033, grant PID2020- 112865RB-I00, and Instituto de Salud Carlos III, grant FIS PI17/00159 (ISCIII/FEDER, UE). E.C.-S. is the recipient of a PFIS predoctoral research fellowship (FI18/00036) cofinanced by the Instituto de Salud Carlos III and the European Social Fund. A.C.-G. acknowledges financial support from the Spanish State Research Agency, AEI/10.13039/501100011033, through the “Severo Ochoa” Program for Centers of Excellence in R&D (SEV-2013-0347, SEV-2017-0712), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Growth hormone remodels the 3D-structure of the mitochondria of inflammatory macrophages and promotes metabolic reprogramming

  • Soler Palacios, Blanca
  • Villares, Ricardo
  • Lucas, Pilar
  • Rodríguez-Frade, José Miguel
  • Cayuela, Ana
  • Piccirillo, Jonathan G.
  • Lombardía, Manuel
  • Delgado Gestoso, David
  • Fernández-García, Miguel
  • Risco, Cristina
  • Barbas, Coral
  • Corrales, Fernando J.
  • Sorzano, Carlos Óscar S.
  • Martínez-Martín, Nuria
  • Conesa, José J.
  • Iborra, Francisco J.
  • Mellado, Mario
17 páginas, 5 figuras, 1 tabla., Introduction: Macrophages are a heterogeneous population of innate immune cells that support tissue homeostasis through their involvement in tissue development and repair, and pathogen defense. Emerging data reveal that metabolism may control macrophage polarization and function and, conversely, phenotypic polarization may drive metabolic reprogramming. Methods: Here we use biochemical analysis, correlative cryogenic fluorescence microscopy and cryo-focused ion-beam scanning electron microscopy. Results: We demonstrate that growth hormone (GH) reprograms inflammatory GM-CSF-primed monocyte-derived macrophages (GM-MØ) by functioning as a metabolic modulator. We found that exogenous treatment of GM-MØ with recombinant human GH reduced glycolysis and lactate production to levels similar to those found in anti-inflammatory M-MØ. Moreover, GH treatment of GM-MØ augmented mitochondrial volume and altered mitochondrial dynamics, including the remodeling of the inner membrane to increase the density of cristae. Conclusions: Our data demonstrate that GH likely serves a modulatory role in the metabolism of inflammatory macrophages and suggest that metabolic reprogramming of macrophages should be considered as a new target to intervene in inflammatory diseases., This work was supported in part by grants from the Spanish Ministry of Science and Innovation (PID2020-114980RB-I00) Agencia Estatal de Investigación/Fondo Europeo de Desarrollo Regional (AEI/FEDER), Unión Europea, and by a grant from the Regional Government of Madrid P2022/BMD-7274. AC was supported by an FPI fellowship from the Spanish Ministry of Science and Innovation (PRE2018-086112) through the Severo Ochoa excellence accreditation SEV-2017-0712-18-1., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (SEV-2017-0712-18-1), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Vaccination strategies in structured populations under partial immunity and reinfection

  • Rodríguez Maroto, Gabriel
  • Atienza-Diez, Iker
  • Ares, Saúl
  • Manrubia Cuevas, Susanna
Optimal protocols of vaccine administration to minimize the effects of infectious diseases depend on a number of variables that admit different degrees of control. Examples include the characteristics of the disease and how it impacts on different groups of individuals as a function of sex, age or socioeconomic status, its transmission mode, or the demographic structure of the affected population. Here we introduce a compartmental model of infection propagation with vaccination and reinfection and analyze the effect that variations on the rates of these two processes have on the progression of the disease and on the number of fatalities. The population is split into two groups to highlight the overall effects on disease caused by different relationships between vaccine administration and various demographic structures. As a practical example, we study COVID-19 dynamics in various countries using real demographic data. The model can be easily applied to any other disease transmitted through direct interaction between infected and susceptible individuals, and any demographic structure, through a suitable estimation of parameter values. Two main conclusions stand out. First, the higher the fraction of reinfected individuals, the higher the likelihood that the disease becomes quasi-endemic. Second, optimal vaccine roll-out depends on demographic structure and disease fatality, so there is no unique vaccination protocol, valid for all countries, that minimizes the effects of a specific disease. Simulations of the general model can be carried out at this interactive webpage Atienza (2021 S2iyrd model simulator)., Grants PID2020-113284GB-C21 (I A, S M) and BADS (PID2019-109320GB-100, S A) funded by MCIN/AEI/10.13039/501100011033. The Spanish MICINN has also funded the 'Severo Ochoa' Centers of Excellence to CNB, SEV2017-0712, and the special Grant PIE 2020-2020E079 (CNB) entitled 'Development of protection strategies against SARS-CoV-2'., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (SEV2017-0712)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Antibody-dependent NK-cell and neutralizing antibody responses against the Spike protein of Wuhan-Hu-1 and Omicron BA.1 SARS-CoV-2 variants in vaccinated experienced and vaccinated naïve individuals

  • Albert, Eliseo
  • Fernández-Soto, Daniel
  • Giménez, Estela
  • Casanovas, José María
  • Zulaica, Joao
  • Álvarez-Rodríguez, Beatriz
  • Rusu, Luciana
  • Geller, Ron
  • Reyburn, H. T.
  • Navarro, David
Antibodies triggering Fc-mediated NK cell activity may contribute to protection against disease caused by SARS-CoV-2 infection in humans. However, how these Fc-mediated humoral responses compare between individuals displaying hybrid immunity (Vac-ex) and those fully vaccinated with no history of SARS-CoV-2 infection (Vac-n) and whether they correlate with neutralizing antibody (NtAb) responses remains largely undetermined. In this retrospective study serum samples from 50 individuals (median age, 44.5 years; range, 11–85; 25 males), 25 Vac-ex and 25 Vac-n were studied. A flow-cytometry-based antibody-mediated NK-cell activation assay was used to quantitate effector NK-cells stimulated to express LAMP1 (lysosomal associated membrane protein 1), MIP1 (Macrophage inflammatory protein 1), and interferon-γ (IFNγ); NK cells isolated from two donors (D1 and D2) were used. NtAb levels targeting the Spike protein of Wuhan-Hu-1 and Omicron BA.1 SARS-CoV-2 variants were quantitated using a SARS-CoV-2 S pseudotyped neutralization assay. Regardless of the SARS-CoV-2 variant S antigen used in the NK-cell activation assay, the frequency of NK cells stimulated to express LAMP-1, MIP1β, and IFNγ was higher in Vac-ex compared with Vac-n (p values ranging from 0.07 to 0.006) for D1; this was only seen for BA.1 when NK cells from D2 were employed. The frequency of functional NK cells activated by antibody binding to either Wuhan-Hu-1 or Omicron BA.1 S protein was not significantly different for both VAC-ex and VAC-n. In contrast, NtAb titers against BA.1 were around 10-fold lower than that against Wuhan-Hu-1. Vac-ex displayed higher NtAb titers against both (sub)variants than Vac-n. NK-cell responses correlated poorly with NtAb titers (ρ ≤ 0.30). The data demonstrate higher cross-reactivity across variants of concern for antibodies triggering Fc-mediated NK cell than for NtAb. Moreover, Vac-Ex seemed to display more robust functional antibody responses as compared with Vac-n., Estela Giménez (Juan Rodés Contract, JR18/00053) and Eliseo Albert (Juan Rodés Contract; JR20/00011) hold contracts funded by the Carlos III Health Institute (co-financed by the European Regional Development Fund, ERDF/FEDER). Beatriz Álvarez-Rodríguez holds a Generalitat Valenciana postdoctoral fellowship (APOSTD/2021/017). This study was supported by Instituto de Salud Carlos III, Madrid, Spain (FIS, PI21/00563) granted to David Navarro, and by the Spanish National Research Council (CSIC, project numbers 202020E079 and CSIC-COVID19-028) and a grant from the Spanish Ministry of Science and Innovation [(MCIU/AEI/FEDER, EU): PID2020-115506RB-I00 (HTR)]. The CNB also acknowledges financial support from the Spanish State Research Agency, AEI/10.13039/501100011033, through the “Severo Ochoa” Program for Centers of Excellence in R&D (SEV-2013-0347, SEV-2017-0712). Daniel Fernández Soto is a recipient of a fellowship (PRE2018-083200) from the Spanish Ministry of Science and Innovation and is a graduate student in the Molecular Biosciences doctoral program of the Autonomous University of Madrid. This research work was also funded by the European Commission – NextGenerationEU (Regulation EU 2020/2094), through the CSIC's Global Health Platform (PTI Salud Global) to Ron Geller and Hugh Reyburn. The funders had no role in study design, data collection and interpretation, or in the decision to submit the work for publication., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Optimized vaccine candidate MVA-S(3P) fully protects against SARS-CoV-2 infection in hamsters

  • Abdelnabi, Rana
  • Pérez, Patricia
  • Astorgano, David
  • Albericio, Guillermo
  • Kerstens, Winnie
  • Thibaut, Hendrik Jan
  • Coelmont, Lotte
  • Weynand, Birgit
  • Labiod, Nuria
  • Delgado, Rafael
  • Montenegro, Dolores
  • Puentes, Eugenia
  • Rodríguez, Esteban
  • Neyts, Johan
  • Dallmeier, Kai
  • Esteban, Mariano
  • García-Arriaza, Juan
The development of novel optimized vaccines against coronavirus disease 2019 (COVID-19) that are capable of controlling the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic and the appearance of different variants of concern (VoC) is needed to fully prevent the transmission of the virus. In the present study, we describe the enhanced immunogenicity and efficacy elicited in hamsters by a modified vaccinia virus Ankara (MVA) vector expressing a full-length prefusion-stabilized SARS-CoV-2 spike (S) protein [termed MVA-S(3P)]. Hamsters vaccinated with one or two doses of MVA-S(3P) developed high titers of S-binding IgG antibodies and neutralizing antibodies against the ancestral Wuhan SARS-CoV-2 virus and VoC beta, gamma, and delta, as well as against omicron, although with a somewhat lower neutralization activity. After SARS-CoV-2 challenge, vaccinated hamsters did not lose body weight as compared to matched placebo (MVA-WT) controls. Consistently, vaccinated hamsters exhibited significantly reduced viral RNA in the lungs and nasal washes, and no infectious virus was detected in the lungs in comparison to controls. Furthermore, almost no lung histopathology was detected in MVA-S(3P)-vaccinated hamsters, which also showed significantly reduced levels of proinflammatory cytokines in the lungs compared to unvaccinated hamsters. These results reinforce the use of MVA-S(3P) as a vaccine candidate against COVID-19 in clinical trials., The authors declare that this study received funding from Fondo COVID-19 grant COV20/00151 (Spanish Health Ministry, Instituto de Salud Carlos III (ISCIII)), Fondo Supera COVID-19 grant (Crue Universidades-Banco Santander), Spanish Research Council (CSIC) grant 202120E079, and funds from Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC) co-financed with FEDER funds (to JG-A), CSIC grant 2020E84, La CaixaImpulse grant CF01-00008, Ferrovial and MAPFRE donations (to ME), a Spanish Ministry of Science and Innovation (MCIN)/Spanish Research Agency (AEI)/10.13039/501100011033 grant (PID2020-114481RB-I00 to JG-A and ME), and internal funding from KU Leuven (to JN) and the Flemish Research Foundation (FWO) Excellence of Science (EOS) program (No. 40007527; VirEOS2) (to KD and JN). This research work was also funded by the European Commission-Next Generation EU through CSIC’s Global Health Platform (PTI Salud Global) (to JG-A and ME). JG-A and ME also acknowledge financial support from the Spanish State Research Agency, AEI/10.13039/501100011033, through the “Severo Ochoa” Programme for Centres of Excellence in R&D (SEV-2013-0347, SEV-2017-0712). The funders were not involved in the study design, collection, analysis, interpretation of data, the writing of this article, or the decision to submit it for publication., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Proteomic snapshot of saliva samples predicts new pathways implicated in SARS-CoV-2 pathogenesis

  • Moreno, Elena
  • Ciordia, Sergio
  • Fátima, Santos Milhano
  • Jiménez, Daniel
  • Martínez-Sanz, Javier
  • Vizcarra, Pilar
  • Ron, Raquel
  • Sánchez-Conde, Matilde
  • Bargiela, Rafael
  • Sánchez-Carrillo, Sergio
  • Moreno, Santiago
  • Corrales, Fernando J.
  • Ferrer, Manuel
  • Serrano-Villar, Sergio
Background Information on the microbiome's human pathways and active members that can affect SARS-CoV-2 susceptibility and pathogenesis in the salivary proteome is very scarce. Here, we studied a unique collection of samples harvested from April to June 2020 from unvaccinated patients. Methods We compared 10 infected and hospitalized patients with severe (n = 5) and moderate (n = 5) coronavirus disease (COVID-19) with 10 uninfected individuals, including non-COVID-19 but susceptible individuals (n = 5) and non-COVID-19 and nonsusceptible healthcare workers with repeated high-risk exposures (n = 5). Results By performing high-throughput proteomic profiling in saliva samples, we detected 226 unique differentially expressed (DE) human proteins between groups (q-value ≤ 0.05) out of 3376 unambiguously identified proteins (false discovery rate ≤ 1%). Major differences were observed between the non-COVID-19 and nonsusceptible groups. Bioinformatics analysis of DE proteins revealed human proteomic signatures related to inflammatory responses, central cellular processes, and antiviral activity associated with the saliva of SARS-CoV-2-infected patients (p-value ≤ 0.0004). Discriminatory biomarker signatures from human saliva include cystatins, protective molecules present in the oral cavity, calprotectins, involved in cell cycle progression, and histones, related to nucleosome functions. The expression levels of two human proteins related to protein transport in the cytoplasm, DYNC1 (p-value, 0.0021) and MAPRE1 (p-value, 0.047), correlated with angiotensin-converting enzyme 2 (ACE2) plasma activity. Finally, the proteomes of microorganisms present in the saliva samples showed 4 main microbial functional features related to ribosome functioning that were overrepresented in the infected group. Conclusion Our study explores potential candidates involved in pathways implicated in SARS-CoV-2 susceptibility, although further studies in larger cohorts will be necessary., This work was supported by Instituto de Salud Carlos III (AC17/00019, PI18/00154, COV20/00349, ICI20/00058, PI21/00141), CRUE-Supera COVID, co-financed by the European Development Regional Fund “A way to achieve Europe” (ERDF), Merck, Sharp & Dohme Investigator Studies Program (code MISP# IIS 60257), Fondo Supera COVID-19 (2020-001), and a mobility grant from the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). This work was also supported by Instituto de Salud Carlos III and Fundación Agencia Española contra el Cáncer (AC17/00022, within the ERA NET TRANSCAN-2) and by Consejo Superior de Investigaciones Científicas (CSIC) projects PIE 202020E108 and SEV 2017-0712. We also acknowledge financial support under Grants PID2020-112758RB-I00 and PDC2021-121534-I00 from the Ministerio de Ciencia e Innovación, Agencia Estatal de Investigación (AEI) (Digital Object Identifier https://doi.org/10.13039/501100011033) and the European Union (“NextGenerationEU”)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Functional antibody responses targeting the Spike protein of SARS-CoV-2 Omicron XBB.1.5 in elderly nursing home residents following Wuhan-Hu-1-based mRNA booster vaccination

  • Sánchez-Simarro, Ángela
  • Fernández-Soto, Daniel
  • Grau, Brayan
  • Albert, Eliseo
  • Giménez, Estela
  • Avilés-Alía, Ana Isabel
  • Gozalbo-Rovira, Roberto
  • Rusu, Luciana
  • Olea, Beatriz
  • Geller, Ron
  • Reyburn, H. T.
  • Navarro, David
The immune effector mechanisms involved in protecting against severe COVID-19 infection in elderly nursing home residents following vaccination or natural infection are not well understood. Here, we measured SARS-CoV-2 Spike (S)-directed functional antibody responses, including neutralizing antibodies (NtAb) and antibody Fc-mediated NK cell activity (degranulation and IFNγ production), against the Wuhan-Hu-1, BA.4/5 (for NtAb), and Omicron XBB.1.5 variants in elderly nursing home residents (n = 39; median age, 91 years) before and following a third (pre- and post-3D) and a fourth (pre- and post-4D) mRNA COVID-19 vaccine dose. Both 3D and 4D boosted NtAb levels against both (sub)variants. Likewise, 3D and 4D increased the ability of sera to trigger both LAMP1- and IFNγ-producing NK cells, in particular against XBB.1.5. In contrast to NtAb titres, the frequencies of LAMP1- and IFNγ-producing NK cells activated by antibodies binding to Wuhan-Hu-1 and Omicron XBB.1.5 S were comparable at all testing times. Stronger functional antibody responses were observed in vaccine-experienced participants compared to vaccine-naïve at some testing times. These findings can contribute to identifying a reliable correlate of protection in elderly nursing home residents against severe COVID-19 and inform future vaccine strategies in this population group., Ángela Sánchez-Simarro has a contract funded by the Carlos III Health Institute (PFIS Contract; FI22/00338). Eliseo Albert holds a contract funded by the Carlos III Health Institute (co-financed by the European Regional Development Fund, ERDF/FEDER): Juan Rodés Contract; JR20/00011. Brayan Grau is supported by a Juan de la Cierva postdoctoral fellowship (FJC2021-046453-I). This study was supported by the Instituto de Salud Carlos III, Madrid, Spain (FIS, PI21/00563) granted to David Navarro, by the Spanish National Research Council (CSIC, project numbers 202020E079 and CSIC-COVID19-028), and a grant from the Spanish Ministry of Science and Innovation [(MCIU/AEI/FEDER, EU): PID2020-115506RB-I00 (HTR)]. The CNB also acknowledges financial support from the Spanish State Research Agency, AEI/https://doi.org/10.13039/501100011033, through the “Severo Ochoa” Programme for Centres of Excellence in R&D (SEV-2013-0347, SEV-2017-0712). D. Fernández Soto is a recipient of a fellowship (PRE2018-083200) from the Spanish Ministry of Science and Innovation and is a graduate student in the Molecular Biosciences doctoral program of the Autonomous University of Madrid. This research work was also funded by the European Commission – NextGenerationEU (Regulation EU 2020/2094), through the CSIC's Global Health Platform (PTI Salud Global) to Ron Geller and Hugh Reyburn., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Additive Allee effect on prey in the dynamics of a Gause predator–prey model with constant or proportional refuge on prey at low or high densities

  • Cortés García, Christian
  • Vera Cuenca, Jasmidt
Assuming that the intrinsic growth of prey is affected by an additive Allee effect, and from which a proportion to the population or critical size of prey is hidden from the predator if the quantity of prey is above or below the critical size, respectively, this paper proposes a predator–prey Gause model composed of two vector fields separated by the critical prey population size. Since the proposed model is not discontinuous, it could have a single interior equilibrium, belonging to one of the vector fields of the model, and a stable limit cycle formed between the two vector fields, and a possible extinction of the prey considering a strong Allee effect., This research was supported by MCIN/AEI/10.13039/501100011033 through grant BADS, no. PID2019-109320GB-100, and the associated FPI contract PRE2019-088899 to Christian Cortés García. The Spanish MICINN has also funded the “Severo Ochoa” Centers of Excellence to CNB , SEV 2017-0712., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Bifurcations in a Leslie–Gower model with constant and proportional prey refuge at high and low density

  • Cortés García, Christian
Assuming that the prey refuge is proportional to the prey density if its population size is below a critical threshold, or constant if its size is above the threshold, this paper proposes, and qualitatively analyzes, a Leslie–Gower predator–prey model assuming alternative feeding and harvesting in predators, and a Holling II function as the predator functional response. From the results of the mathematical analysis to the predator–prey models with proportional or constant prey refuge, the proposed model retains the same bifurcation cases obtained for each model analyzed. However, appropriate alterations of the parameters representing the critical threshold of prey population size and harvest in predators allows the formation of at least one limit cycle, stable or unstable, that lives in both vector fields of the proposed model., This research was supported by MCIN/AEI/10.13039/501100011033 through grant BADS, no. PID2019- 109320GB-100, and the associated FPI contract PRE2019-088899 to Christian Cort ́es Garc ́ıa. The Spanish MICINN has also funded the “Severo Ochoa” Centers of Excellence to CNB, SEV 2017-0712., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Crosstalk between Pseudomonas aeruginosa antibiotic resistance and virulence mediated by phenylethylamine

  • Muñoz-Cazalla, Ada
  • Martínez, José L.
  • Laborda, Pablo
Multidrug efflux pumps are among the main Pseudomonas aeruginosa antibiotic-resistance determinants. Besides, efflux pumps are also involved in other relevant activities of bacterial physiology, including the quorum sensing-mediated regulation of bacterial virulence. Nevertheless, despite the relevance of efflux pumps in bacterial physiology, their interconnection with bacterial metabolism remains obscure. The effect of several metabolites on the expression of P. aeruginosa efflux pumps, and on the virulence and antibiotic resistance of this bacterium, was studied. Phenylethylamine was found to be both inducer and substrate of MexCD-OprJ, an efflux pump involved in P. aeruginosa antibiotic resistance and in extrusion of precursors of quorum-sensing signals. Phenylethylamine did not increase antibiotic resistance; however, the production of the toxin pyocyanin, the tissue-damaging protease LasB and swarming motility were reduced in the presence of this metabolite. This decrease in virulence potential was mediated by a reduction of lasI and pqsABCDE expression, which encode the proteins that synthesise the signalling molecules of two quorum-sensing regulatory pathways. This work sheds light on the interconnection between virulence and antibiotic-resistance determinants, mediated by bacterial metabolism, and points to phenylethylamine as an anti-virulence metabolite to be considered in the study of therapies against P. aeruginosa infections., MCIN/AEI/10.13039/501100011033, Grant/Award Number: PID2020- 113521RB-I00 and SEV-2017-0712; Ministerio de Asuntos Económicos y Transformación Digital, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Highly Attenuated Poxvirus-Based Vaccines Against Emerging Viral Diseases

  • Perdiguero, Beatriz
  • Pérez, Patricia
  • Marcos-Villar, Laura
  • Albericio, Guillermo
  • Astorgano, David
  • Álvarez, Enrique
  • Sin, Laura
  • Gómez, Carmen Elena
  • García-Arriaza, Juan
  • Esteban, Mariano
Although one member of the poxvirus family, variola virus, has caused one of the most devastating human infections worldwide, smallpox, the knowledge gained over the last 30 years on the molecular, virological and immunological mechanisms of these viruses has allowed the use of members of this family as vectors for the generation of recombinant vaccines against numerous pathogens. In this review, we cover different aspects of the history and biology of poxviruses with emphasis on their application as vaccines, from first- to fourth-generation, against smallpox, monkeypox, emerging viral diseases highlighted by the World Health Organization (COVID-19, Crimean-Congo haemorrhagic fever, Ebola and Marburg virus diseases, Lassa fever, Middle East respiratory syndrome and severe acute respiratory syndrome, Nipah and other henipaviral diseases, Rift Valley fever and Zika), as well as against one of the most concerning prevalent virus, the Human Immunodeficiency Virus, the causative agent of Acquired Immunodeficiency Syndrome. We discuss the implications in human health of the 2022 monkeypox epidemic affecting many countries, and the rapid prophylactic and therapeutic measures adopted to control virus dissemination within the human population. We also describe the preclinical and clinical evaluation of the Modified Vaccinia virus Ankara and New York vaccinia virus poxviral strains expressing heterologous antigens from the viral diseases listed above. Finally, we report different approaches to improve the immunogenicity and efficacy of poxvirus-based vaccine candidates, such as deletion of immunomodulatory genes, insertion of host-range genes and enhanced transcription of foreign genes through modified viral promoters. Some future prospects are also highlighted., We thank various agencies for continuous funding support, such as Fondo COVID-19 grant COV20/00151 [Spanish Health Ministry, Instituto de Salud Carlos III (ISCIII)], Fondo Supera COVID-19 grant (Crue Universidades-Banco Santander) and Spanish Research Council (CSIC) grant 202120E079 (to JG-A); Red Sida RD16/0025/0002, CSIC grant 2020E84, La CaixaImpulse grant CF01-00008, Ferrovial and MAPFRE donations (to ME); Spanish Ministry of Science and Innovation (MCIN)/Spanish Research Agency (AEI)/10.13039/501100011033 grants PID2020-114481RB-I00 (to JG-A and ME) and PID2020-117425RB-C22 (to CEG); and funds from Centro de Investigacio ́n Biome ́dica en Red de Enfermedades Infecciosas (CIBERINFEC) co-financed with FEDER funds (to CEG and JG-A). We have also received funding from the European Commission-Next Generation EU through CSIC’s Global Health Platform (PTI Salud Global) (to JG-A and ME). We also acknowledge financial support from the Spanish State Research Agency, AEI/10.13039/501100011033, through the “Severo Ochoa” Programme for Centres of Excellence in R&D (SEV-2013-0347, SEV-2017-0712)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

MVA-based vaccine candidates expressing SARS-CoV-2 prefusion-stabilized spike proteins of the Wuhan, Beta or Omicron BA.1 variants protect transgenic K18-hACE2 mice against Omicron infection and elicit robust and broad specific humoral and cellular immune responses

  • Pérez Ramírez, Patricia
  • Astorgano, David
  • Albericio, Guillermo
  • Flores, Sara
  • Sánchez-Corzo, Cristina
  • Noriega, María A.
  • Sánchez-Cordón, Pedro J.
  • Labiod, Nuria
  • Delgado, Rafael
  • Casasnovas, José María
  • Esteban, Mariano
  • García-Arriaza, Juan
Despite the decrease in mortality and morbidity due to SARS-CoV-2 infection, the incidence of infections due to Omicron subvariants of SARS-CoV-2 remains high. The mutations acquired by these subvariants, mainly concentrated in the receptor-binding domain (RBD), have caused a shift in infectivity and transmissibility, leading to a loss of effectiveness of the first authorized COVID-19 vaccines, among other reasons, by neutralizing antibody evasion. Hence, the generation of new vaccine candidates adapted to Omicron subvariants is of special interest in an effort to overcome this immune evasion. Here, an optimized COVID-19 vaccine candidate, termed MVA-S(3P_BA.1), was developed using a modified vaccinia virus Ankara (MVA) vector expressing a full-length prefusion-stabilized SARS-CoV-2 spike (S) protein from the Omicron BA.1 variant. The immunogenicity and efficacy induced by MVA-S(3P_BA.1) were evaluated in mice in a head-to-head comparison with the previously generated vaccine candidates MVA-S(3P) and MVA-S(3Pbeta), which express prefusion-stabilized S proteins from Wuhan strain and Beta variant, respectively, and with a bivalent vaccine candidate composed of a combination of MVA-S(3P) and MVA-S(3P_BA.1). The results showed that all four vaccine candidates elicited, after a single intramuscular dose, protection of transgenic K18-hACE2 mice challenged with SARS-CoV-2 Omicron BA.1, reducing viral loads, histopathological lesions, and levels of proinflammatory cytokines in the lungs. They also elicited anti-S IgG and neutralizing antibodies against various Omicron subvariants, with MVA-S(3P_BA.1) and the bivalent vaccine candidate inducing higher titers. Additionally, an intranasal immunization in C57BL/6 mice with all four vaccine candidates induced systemic and mucosal S-specific CD4+ and CD8+ T-cell and humoral immune responses, and the bivalent vaccine candidate induced broader immune responses, eliciting antibodies against the ancestral Wuhan strain and different Omicron subvariants. These results highlight the use of MVA as a potent and adaptable vaccine vector against new emerging SARS-CoV-2 variants, as well as the promising feature of combining multivalent MVA vaccine candidates., The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This research was supported by Fondo COVID-19 grant COV20/00151 (Spanish Health Ministry, Instituto de Salud Carlos III (ISCIII)), Fondo Supera COVID-19 grant (Crue Universidades-Banco Santander), CSIC grant 202120E079, grant CNS2022-135511 funded by the Spanish Ministry of Science, Innovation and Universities (MCIU)/Spanish Research Agency (AEI)/10.13039/501100011033 and by the European Union NextGenerationEU/PRTR to promote the consolidation of research, and funds from Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC) co-financed with FEDER funds (to JG-A); CSIC grant 2020E84, la Caixa Banking Foundation grant CF01-00008, Ferrovial, and MAPFRE donations (to ME); and Spanish MCIU/AEI/10.13039/501100011033 grant PID2020-114481RB-I00 (to JG-A and ME). This research work was also funded by the European Commission-NextGenerationEU, through CSIC’s Global Health Platform (PTI Salud Global) (to JG-A and ME). JG-A also received grants from the European Commission HORIZON-HLTH-2023-DISEASE-03-18 (Project MARVAX: 101137183 and Project FLAVIVACCINE: 101137006). JG-A and ME also acknowledges financial support from the Spanish AEI/10.13039/501100011033, through the “Severo Ochoa” Programme for Centres of Excellence in R&D (SEV-2013-0347, SEV-2017-0712). JC acknowledges MCIU and CSIC support (project number 202020E079). RD received grants from ISCIII (FIS PI2100989), the European Commission Horizon 2020 Framework Programme (Project VIRUSCAN FETPROACT-2016: 731868 and Project EPIC-CROWN-2: 101046084), and Fundación Caixa-Health Research HR18-00469 (Project StopEbola). The funders were not involved in the study design, collection, analysis, interpretation of data, the writing of this article, or the decision to submit it for publication., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Population dynamics in a Leslie–Gower predator–prey model with predator harvesting at high densities

  • Cortés García, Christian
In this paper, we propose a Leslie–Gower predator–prey model in which the predator can only be captured when its population size exceeds a critical value; the mean growth rate of the prey in the absence of the predator is subject to a semi-saturation rate that affects its birth curve, and the interaction between the two species is defined by a Holling II predation functional with alternative food for the predator. Since the proposed model is equivalent to a Filippov system, its mathematical analysis leads to a local study of the equilibria in each vector field corresponding to the proposed model, in addition to the study of the stability of its pseudo-equilibria located on the curve separating the two vector fields. In particular, the model could have between one and three pseudo-equilibria and at least one limit cycle surrounding one or two inner equilibria, locally unstable points., This research was supported by MCIN/AEI/10.13039/501100011033 through grant BADS, no. PID2019-109320GB-100, and the associated FPI contract PRE2019-088899 to Christian Cortés García. The Spanish MICINN has also funded the “Severo Ochoa” Centers of Excellence to CNB, SEV 2017-0712., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Functional characteristics of plitidepsin as an antiviral treatment against monkeypox virus infection

  • Albericio, Guillermo
  • Rodríguez-Martín, Daniel
  • Avilés, Pablo
  • Cuevas, Carmen
  • Guillén-Navarro, María José
  • Noriega, María A.
  • Flores, Sara
  • Sánchez-Cordón, Pedro J.
  • Astorgano, David
  • Pérez Ramírez, Patricia
  • Esteban, Mariano
  • García-Arriaza, Juan
Monkeypox virus (MPXV), closely related to variola virus, causes mpox, a zoonotic disease traditionally endemic to Central Africa. However, recent outbreaks have increased human transmission of MPXV clades. In 2022, global MPXV spread was linked to clade IIb, whereas in 2024, the more pathogenic clade Ib became predominant. These trends raised concerns about sustained human transmission, prompting the WHO to declare mpox a Public Health Emergency of International Concern. Despite the availability of smallpox vaccines, their protective efficacy against mpox remains limited. Additionally, the limited efficacy of current smallpox antivirals, such as Tecovirimat and Brincidofovir, alongside growing concerns about the emergency of tecovirimat resistance mutants, underscores the need for new therapeutic options. Given these challenges, novel antiviral strategies with different mechanisms of action are urgently needed to control MPXV outbreaks. Plitidepsin, a cyclodepsipeptide drug initially approved for cancer treatment, has demonstrated potent antiviral activity against multiple viruses by targeting eukaryotic elongation factor 1 alpha (eEF1A). Here, we have evaluated the antiviral activity of plitidepsin against MPXV infection. In cultured cells, plitidepsin exhibited strong antiviral effects, with a favorable therapeutic index and low cytotoxicity. In CAST/EiJ mice, a highly susceptible MPXV model, plitidepsin significantly reduced viral replication in the lungs. Additionally, treated mice displayed a marked reduction in inflammatory lung lesions and proinflammatory cytokines, suggesting immunomodulatory effects. These findings indicate plitidepsin as a promising candidate for mpox treatment. Further studies are needed to explore its potential as a standalone or combination therapy, supporting clinical evaluation for mpox treatment., This work was supported by a research agreement with PharmaMar S.A., by grant CNS2022-135511 funded by the Spanish Ministry of Science, Innovation and Universities (MICIU)/Spanish Research Agency (AEI)/10.13039/501100011033 and by the European Union NextGenerationEU/PRTR to promote the consolidation of research, by Spanish Research Council (CSIC) grant 202120E079, and by funds from Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC) co-financed with FEDER funds (to J.G.-A.); by CSIC grant 2020E84 (to M.E.); and by Spanish Ministry of Science and Innovation (MCIN)/Spanish Research Agency (AEI)/10.13039/501100011033 grant (PID2020-114481RB-I00) (to J.G.-A. and M.E.). DA received an FPI predoctoral research contract (reference PRE2021-099058) associated to the MCIU/AEI/10.13039/501100011033 grant PID2020-114481RB-I00. This research work was also funded by the European Commission-NextGenerationEU, through CSIC's Global Health Platform (PTI Salud Global) (to J.G.-A. and M.E.). J.G.-A. and M.E. acknowledges financial support from the Spanish State Research Agency, AEI/10.13039/501100011033, through the “Severo Ochoa” Programme for Centres of Excellence in R&D (SEV-2013-0347, SEV-2017-0712, CEX2023-001386-S). The funders were not involved in the study design, collection, analysis, interpretation of data, the writing of this article, or the decision to submit it for publication., With funding form the Spanish government through the "Severa Ochoa Centre of Excellence" accreditation (SEV-2013-0347)., With funding form the Spanish government through the "Severa Ochoa Centre of Excellence" accreditation (SEV-2017-0712)., With funding form the Spanish government through the "Severa Ochoa Centre of Excellence" accreditation (CEX2023-001386-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

HIV-1 envelope glycoprotein modulates CXCR4 clustering and dynamics on the T cell membrane

  • Quijada-Freire, Adriana
  • Santiago, César
  • García-Cuesta, Eva María
  • Soler Palacios, Blanca
  • Gardeta, Sofia R.
  • San Sebastian, Enara
  • Armendariz- Burgoa, Eva
  • Puertas, Maria Carmen
  • Villares, Ricardo
  • Garaigorta, Urtzi
  • Luis Ignacio González- Granado
  • Rodríguez-Frade, José Miguel
  • Jakub Chojnacki
  • Javier Martinez-Picado
  • Mellado, Mario
HIV-1 entry into susceptible cells requires the dynamic interaction of its envelope (Env) glycoprotein with the host cell receptor CD4 and a co-receptor, either CCR5 or CXCR4. While the core molecular mechanisms driving Env-receptor interactions and subsequent membrane fusion are well characterized, the precise nanoscale spatial reorganization of these co-receptors at the viral binding site remains poorly defined. In this study, we employed single-particle tracking total internal reflection fluorescence (SPT-TIRF) microscopy to quantitatively analyze nanoscale organizational changes of CXCR4 on the surface of human CD4+ T cells following binding by X4-tropic HIV-1. Our data reveal that both recombinant X4-gp120 and virus-like particles expressing physiological levels of X4 Env proteins (gp120 and gp41) promote CXCR4 clustering, a phenomenon linked to cell infection. Furthermore, these ligands induced oligomerization of CXCR4R334X, a naturally occurring mutant associated with WHIM syndrome that supports HIV-1 infection, but fails to oligomerize in response to CXCL12. Our findings establish a link between CXCR4 clustering and HIV-1 infection, enhancing our understanding of the initial events in viral attachment and entry. These results further suggest that HIV-1 depends on a specific spatial arrangement of co-receptors, distinct from that induced by their natural chemokine ligands, highlighting the critical role of cell-surface receptor spatial organization in dictating cellular function., Spanish National Plan for Scientific and Technical Research and Innovation (PID2020-114980RB-I00) Fundación para el Conocimiento Madri+d (CAM20_CNB_AI_07) Federación Española de Enfermedades Raras (FIS PI21/01642) Spanish National Plan for Scientific and Technical Research and Innovation (PID2023-146301OB-I00) Spanish National Plan for Scientific and Technical Research and Innovation (PID2022-140651NB-I00) Spanish National Plan for Scientific and Technical Research and Innovation (PID2022-139271OB-I00) Centro de Investigación Biotecnológica en Red de Enfermedades Infecciosas (CB21/13/00063) Centro Nacional de Biotecnología (SEV-2017-0712) Spanish National Plan for Scientific and Technical Research and Innovation (PRE2018-083201) Spanish National Plan for Scientific and Technical Research and Innovation (PRE2019-087966) Spanish National Plan for Scientific and Technical Research and Innovation (PRE2022-000847), Peer reviewed, Modelo experimental alternativo-NAM, in vitro - Tipos celulares
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Homologous MVA and heterologous DREP/MVA vaccine regimens induce robust and durable immune responses against SARS-CoV-2

  • Pérez, Patricia
  • Esteso, Gloria
  • Noriega, María A.
  • Vidakovics, Laura Perez
  • Liljeström, Peter
  • McInerney, Gerald M
  • Esteban, Mariano
  • García-Arriaza, Juan
Despite the success of current COVID-19 vaccines, the immunity they generate wanes over time, requiring periodic boosters. The limited durability of memory responses, particularly from mRNA vaccines, remains a major challenge for achieving long-term protection. Developing vaccines that induce more sustained immunity would lessen the need for frequent revaccination, improving global vaccination logistics, especially in resource-limited settings. DNA-launched self-amplifying RNA replicons (DREP) and modified vaccinia virus Ankara (MVA) vectors are promising vaccine platforms capable of inducing potent humoral and cellular immunity. In this study, we evaluated SARS-CoV-2-specific immune responses in C57BL/6 mice following homologous and heterologous prime/boost regimens combining DREP- and MVA-based vaccines expressing the spike (S) protein from either the ancestral Wuhan strain or the Omicron XBB.1.5 variant. Homologous (DREP/DREP, MVA/MVA) and heterologous (DREP/MVA) regimens were followed for six months. MVA-S(3P)-based boosters elicited robust and durable anti-S IgG antibodies cross-recognizing multiple variants, with minimal decay over time. Neutralization mapped to the booster antigen: MVA-S(3PWuhan) induced neutralization of the ancestral strain, while MVA-S(3PXBB.1.5) selectively neutralized Omicron subvariants, maintaining high titers for at least six months. MVA-S(3P) boosters also enhanced antibody Fc-effector functions, memory B cells, and T follicular helper responses. Early after boosting, heterologous DREP/MVA regimens induced stronger CD4⁺ and CD8⁺ T-cell responses, while at six months all MVA-S(3P)-boosted groups maintained superior, long-lived cellular immunity. Collectively, MVA-S(3P)-based boosters improved the magnitude, breadth, and durability of humoral and cellular responses, supporting their strategic use in homologous and heterologous DREP/MVA vaccination regimens against SARS-CoV-2 and emerging variants., Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. This work was supported by CSIC grant 202120E079, grant CNS2022-135511 funded by the Spanish Ministry of Science, Innovation and Universities (MCIU)/Spanish Research Agency (AEI)/https://doi.org/10.13039/501100011033 and by the European Union NextGenerationEU/PRTR to promote research consolidation, as well as funds from the Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC) co-financed with FEDER funds (to JG-A). Additional support was provided by CSIC grant 2020E84 (to ME), and by Spanish MCIU/AEI/https://doi.org/10.13039/501100011033 grant PID2020-114481RB-I00 (to JG-A and ME). This research work also received funding from the European Commission-NextGenerationEU, through CSIC’s Global Health Platform (PTI Salud Global) (to JG-A and ME). JG-A received further funding from the European Commission HORIZON-HLTH-2023-DISEASE-03-18 (Project MARVAX: 101137183 and Project FLAVIVACCINE: 101137006). JG-A and ME also acknowledge financial support from the Spanish AEI/https://doi.org/10.13039/501100011033 through the “Severo Ochoa” Programme for Centres of Excellence in R&D (SEV-2017-0712, CEX2023-001386-S). The funders were not involved in the study design, collection, analysis, interpretation of data, the writing of this article, or the decision to submit it for publication., Peer reviewed, Modelo experimental animal, Mamíferos - Roedores
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Rapid phenotypic convergence towards collateral sensitivity in clinical isolates of Pseudomonas aeruginosa presenting different genomic backgrounds

  • Hernando-Amado, S.
  • López-Causapé, C.
  • Laborda, P.
  • Sanz-García, F.
  • Oliver, A.
  • Martínez, J. L.
Collateral sensitivity (CS) is an evolutionary trade-off by which acquisition of resistance to an antibiotic leads to increased susceptibility to another. This Achilles’ heel of antibiotic resistance could be exploited to design evolution-based strategies for treating bacterial infections. To date, most studies in the field have focused on the identification of CS patterns in model strains. However, one of the main requirements for the clinical application of this trade-off is that it must be robust and has to emerge in different genomic backgrounds, including preexisting drug-resistant isolates, since infections are frequently caused by pathogens already resistant to antibiotics. Here, we report the first analysis of CS robustness in clinical strains of Pseudomonas aeruginosa presenting different ab initio mutational resistomes. We identified a robust CS pattern associated with short-term evolution in the presence of ciprofloxacin of clinical P. aeruginosa isolates, including representatives of high-risk epidemic clones belonging to sequence type (ST) 111, ST175, and ST244. We observed the acquisition of different ciprofloxacin resistance mutations in strains presenting varied STs and different preexisting mutational resistomes. Importantly, despite these genetic differences, the use of ciprofloxacin led to a robust CS to aztreonam and tobramycin. In addition, we describe the possible application of this evolutionary trade-off to drive P. aeruginosa infections to extinction by using the combination of ciprofloxacin-tobramycin or ciprofloxacin-aztreonam. Our results support the notion that the identification of robust patterns of CS may establish the basis for developing evolution-informed treatment strategies to tackle bacterial infections, including those due to antibiotic-resistant pathogens. IMPORTANCE Collateral sensitivity (CS) is a trade-off of antibiotic resistance evolution that could be exploited to design strategies for treating bacterial infections. Clinical application of CS requires it to robustly emerge in different genomic backgrounds. In this study, we performed an analysis to identify robust patterns of CS associated with the use of ciprofloxacin in clinical isolates of P. aeruginosa presenting different mutational resistomes and including high-risk epidemic clones (ST111, ST175, and ST244). We demonstrate the robustness of CS to tobramycin and aztreonam and the potential application of this evolutionary observation to drive P. aeruginosa infections to extinction. Our results support the notion that the identification of robust CS patterns may establish the basis for developing evolutionary strategies to tackle bacterial infections, including those due to antibiotic-resistant pathogens.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Multiple Layered Control of the Conjugation Process of the Bacillus subtilis Plasmid pLS20

  • Meijer, Wilfried J. J.|||0000-0003-1842-0049
  • Boer, Roeland|||0000-0001-5949-6627
  • Ares, Saúl
  • Alfonso, Carlos|||0000-0001-7165-4800
  • Rojo, Fernando|||0000-0003-1848-7745
  • Luque-Ortega, Juan Román|||0000-0003-3206-7480
  • Wu, Ling Juan
Bacterial conjugation is the main horizontal gene transfer route responsible for the spread of antibiotic resistance, virulence and toxin genes. During conjugation, DNA is transferred from a donor to a recipient cell via a sophisticated channel connecting the two cells. Conjugation not only affects many different aspects of the plasmid and the host, ranging from the properties of the membrane and the cell surface of the donor, to other developmental processes such as competence, it probably also poses a burden on the donor cell due to the expression of the large number of genes involved in the conjugation process. Therefore, expression of the conjugation genes must be strictly controlled. Over the past decade, the regulation of the conjugation genes present on the conjugative Bacillus subtilis plasmid pLS20 has been studied using a variety of methods including genetic, biochemical, biophysical and structural approaches. This review focuses on the interplay between Rco, Rap and Phr*, the proteins that control the activity of the main conjugation promoter P located upstream of the conjugation operon. Proper expression of the conjugation genes requires the following two fundamental elements. First, conjugation is repressed by default and an intercellular quorum-signaling system is used to sense conditions favorable for conjugation. Second, different layers of regulation act together to repress the P promoter in a strict manner but allowing rapid activation. During conjugation, ssDNA is exported from the cell by a membrane-embedded DNA translocation machine. Another membrane-embedded DNA translocation machine imports ssDNA in competent cells. Evidences are reviewed indicating that conjugation and competence are probably mutually exclusive processes. Some of the questions that remain unanswered are discussed.